Patent Grant
7105032
The invention relates to an agent for dyeing (coloring) keratin-containing fibers, particularly human hair, comprising 1,2-dihydropyrimidinium derivatives in combination with reactive carbonyl compounds, the use of this combination in compositions for dyeing keratin-containing fibers, for color restoration or shading keratin-containing fibers that are already dyed, as well as a process for dyeing keratin-containing fibers, particularly human hair.
For dyeing keratin-containing fibers, generally either substantive dyestuffs or oxidation dyestuffs are used, the latter resulting from oxidative coupling of one or more developer components with each other or with one or more coupler components. Coupler and developer components are also referred to as oxidation dyestuff precursors.
Usually, primary aromatic amines with a further free or substituted hydroxyl or amino group in the para or ortho position, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazolone derivatives as well as 2,4,5,6-tetraminopyrimidine and its derivatives are employed as developer components.
Specific representatives are for example p-phenylenediamine, p-toluylenediamine, 2,4,5,6-tetraminopyrimidine, p-aminophenol, N,N-bis-(2-hydroxyethyl)-p-phenylenediamine, 2-(2,5-diaminophenyl)ethanol, 2-(2,5-diaminophenoxy)ethanol, 1-phenyl-3-carboxyamido-4-aminopyrazol-5-one, 4-amino-3-methylphenol, 2-aminomethyl-4-aminophenol, 2-hydroxymethyl-4-aminophenol, 2-hydroxy-4,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine and 2,5,6-triamino-4-hydroxypyrimidine.
Generally, m-phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones, m-aminophenols and substituted pyridine derivatives. Suitable coupler substances are particularly α-naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 5-amino-2-methylphenol, m-aminophenol, resorcinol, resorcinol monomethylether, m-phenylenediamine, 2,4-diaminophenoxyethanol, 2-amino-4-(2-hydroxyethylamino)anisole (Lehmann's Blue), 1-phenyl-3-methylpyrazol-5-one, 2,4-dichloro-3-aminophenol, 1,3-bis-(2,4-diaminophenoxy)propane, 2-chlororesorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 3-amino-6-methoxy-2-methylaminopyridine and 3,5-diamino-2,6-dimethoxypyridine are employed as coupler components.
With respect to other customary dyestuff components, reference is expressly made to the series “Dermatology”, edited by Ch. Culnan, H. Maibach, publisher Marcel Dekker Inc., New York, Basel, 1986, vol. 7, Ch. Zviak, The Science of Hair Care, ch. 7, pages 248–250 (substantive dyestuffs), and ch. 8, pages 264–267 (oxidation dyestuffs) and the “European Inventory of Cosmetic Raw Materials”, 1996, published by the European Commission, obtainable as a floppy disk from the Bundesverband der deutschen Industrie-und Handelsunternehmen für Arzneimittel, Reformwaren und Körperpflegemittel e.V., Mannheim.
Although intense colorations with good fastness properties can be obtained with oxidation dyestuffs, the development of the color generally occurs however, under the influence of oxidizing agents such as e.g. H2O2, which in some cases can result in damage to the fibers. The preparation of oxidation hair colorations in the reddish range with satisfactory fastness properties still proves to be problematic, particularly for very good wash fastness and rubbing fastness. Furthermore, some oxidation dyestuff precursors or particular mixtures of oxidation dyestuff precursors can sometimes produce a sensitizing effect on persons with sensitive skin. Substantive dyestuffs are applied under milder conditions but have the disadvantage that the colorations often suffer from inadequate fastness properties.
Colorants comprising 1,2-dihydropyrimidinium derivatives, together with their use for dyeing keratin-containing fibers or for color restoration or shading keratin-containing fibers that have already been dyed, are so far unknown.
Reactions of pyrimidones as methylene bases are described in the publication of H. Baumann et al., Liebigs Ann. Chem., 1968, 717, 124–136. A hair colorant comprising 1,2-dihydropyrimidinium derivatives, or the use of the disclosed hemicyanines for dyeing keratin-containing fibers is not suggested.
In the German patent application DE-A1-2047431, cationic methine dyestuffs are described for the coloration of anionically modified fibers such as acid modified polyesters or acrylonitrile polymers. For the synthesis of cationic methine dyestuffs, 3,4-dihydro-3-methyl-4-methylenequinazol-2-one and 1,3,6-trimethyl-4-methylenepyrimidine-2-one inter alia are used as well as imperatively terephthalaldehyde.
In the German patent application DE-A1-2165913, a process for the manufacture of bleached images by using light-sensitive dyestuffs is proposed. The claimed light-sensitive dyestuffs belong to the class of pyrimidone or thiopyrimidone dyestuffs.
The object of the present invention is to provide colorants for keratin-containing fibers, particularly human hair, which with respect to depth of color, gray coverage and fastness properties such as for example light-, rubbing- and wash fastness as well as perspiration fastness and cold-waving fastness, are qualitatively at least equal, particularly in the reddish range, to typical oxidation hair colorants, without however being necessarily dependent on oxidizing agents such as for example H2O2. Moreover, the dyes must not possess any, or only a very low degree of sensitization.
Surprisingly it has now been found that 1,2-dihydropyrimidinium derivatives in combination with compounds comprising at least one reactive carbonyl group, are outstandingly suitable for dyeing keratin-containing fibers—even in the absence of oxidizing agents. They provide colorations with outstanding brilliance and depth of color and lead to many color shades. In particular, colorations with improved fastness properties are obtained across a range of shades from yellow through yellow-brown, orange, brown-orange, brown, red, red-violet to blue-violet and black. The addition of oxidizing agents should not necessarily be excluded, however.
The subject of the invention is an agent for dyeing keratin-containing fibers, particularly human hair, comprising at least one 1,2-dihydropyrimidinium derivative according to Formula 1 and/or its enamine form,
wherein
In a preferred embodiment, Y stands for an oxygen or a sulfur atom, particularly preferably for an oxygen atom.
Preferably, X− stands for a halide, particularly chloride, bromide or iodide, p-toluenesulfonate, tetrafluoroborate, trifluoromethanesulfonate, hexafluorophosphate, 0.5 sulfate or hydrogen sulfate. The anions chloride, bromide, iodide, hydrogen sulfate or p-toluenesulfonate are particularly preferred for use as X−.
R5 stands preferably for a hydrogen atom.
At least one group R3 or R4 according to Formula I stands for a C1–C6 alkyl group. This alkyl group carries on its α-carbon atom preferably at least two hydrogen atoms. Particularly preferred alkyl groups are methyl, ethyl, propyl, n-butyl, iso-butyl, n-pentyl, iso-pentyl, n-hexyl. Quite particularly preferred is when R3 and R4 independently of one another stand for hydrogen or a methyl group, wherein at least one group R3 or R4 means a methyl group.
Preferably the compounds according to Formula I are selected from the group consisting of 1,2-dihydro-1,3,4,6-tetramethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-di(2-hydroxyethyl)-4,6-dimethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-diphenyl-4,6-dimethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-di(2-hydroxyethyl)-4,6-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diphenyl-4,6-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3,4-trimethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3,4-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4-methyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4-methyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-di(2-hydroxyethyl)-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-di(2-hydroxyethyl)-4-methyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diphenyl-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-diphenyl-4-methyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3,4,5,6-pentamethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-di(2-hydroxyethyl)-4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diphenyl-4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-di(2-hydroxyethyl)-4,6-dimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diphenyl-4,6-dimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3,4-trimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3,4-trimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl-4-methyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4-methyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4-methyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4-methyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-di(2-hydroxyethyl)-4-methyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-di(2-hydroxyethyl)-4-methyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diphenyl-4-methyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diphenyl-4-methyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-3,4-dimethyl-2-oxo-quinazolinium chloride, 1,2-dihydro-3,4-dimethyl-2-oxo-quinazolinium p-toluenesulfonate, 1,2-dihydro-3,4-dimethyl-2-thioxo-quinazolinium chloride, 1,2-dihydro-3,4-dimethyl-2-thioxo-quinazolinium p-toluenesulfonate, 1,2-dihydro-1,3,4-trimethyl-2-thioxo-quinazolinium hydrogen sulfate, 1,3,4-trimethyl-2-oxo-2,3,5,6,7,8-hexahydroquinolinium hydrogen sulfate, 1,3,4-trimethyl-2-thioxo-2,3,5,6,7,8-hexahydroquinolinium hydrogen sulfate, 1,3,4-trimethyl-2-oxo-3,5,6,7-tetrahydro-2H-cyclopenta[a]pyrimidinium hydrogen sulfate and 1,3,4-trimethyl-2-thioxo-3,5,6,7-tetrahydro-2H-cyclopenta[a]pyrimidinium hydrogen sulfate.
Quite particularly preferred inventive compounds according to Formula I of component A are selected from 1,2-dihydro-1,3,4,6-tetramethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-oxopyrimidinium hydrogen sulfate, 1,2-dihydro-1,3,4-trimethyl-2-oxopyrimidinium chloride, 1,2-dihydro-4,6-dimethyl-1,3-dipropyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-thioxopyrimidinium hydrogen sulfate and 1,2-dihydro-1,3,4,5,6-pentamethyl-2-oxopyrimidinium chloride.
In the following should be mentioned examples of groups or radicals cited as substituents in the context of this application. Examples of C1–C6 alkyl radicals are the groups methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl and tert-butyl, n-pentyl and n-hexyl. Preferred alkyl radicals are propyl, methyl and ethyl. Examples of appropriate cyclic alkyl groups are cyclopentyl and cyclohexyl. Examples of C2–C6 alkenyl radicals are vinyl and allyl. According to the invention, preferred exemplary C1–C6 alkoxy radicals are a methoxy or ethoxy group. The methoxycarbonyl-ethoxycarbonyl-n-propoxycarbonyl-, isopropoxycarbonyl-, n-butoxycarbonyl-, sec-butoxycarbonyl- and tert-butoxycarbonyl are examples of C1–C4 alkoxycarbonyl groups; the methoxycarbonyl and ethoxycarbonyl groups are here particularly preferred. In addition, preferred examples of a C1–C6 hydroxyalkyl group can be cited as hydroxymethyl-, 2-hydroxyethyl-, 2-hydroxypropyl-, 3-hydroxypropyl-, 4-hydroxybutyl-, 5-hydroxypentyl- and a 6-hydroxyhexyl group. A 2-hydroxyethyl group is particularly preferred. The methoxyethyl-, ethoxyethyl-, methoxypropyl-, methoxybutyl-, ethoxybutyl- and the methoxyhexyl group are examples of inventive C1–C6 alkoxy C1–C6 alkyl groups. Examples of a C2–C6 polyhydroxyalkyl group are the 2,3-dihydroxypropyl group, 3,4-dihydroxybutyl group and the 2,4-dihydroxybutyl group. A preferred hydroxy C1–C6 alkoxy group is the 2-hydroxyethoxy group. Preferred aryl groups are phenyl, naphthyl and biphenyl. Examples of halogen atoms are F—, Cl—, Br— or I atoms, wherein Cl atoms are quite particularly preferred. Preferred aryl C1–C6 aminoalkyl groups are benzyl and 2-phenylethyl. The aminomethyl-, 2-aminoethyl-, 3-aminopropyl-, 2-dimethylaminoethyl-, diethylaminomethyl-, dimethylaminomethyl-, 2-methylaminoethyl-, dimethylamino-, piperidinomethyl-, pyrrolidinomethyl-, morpholinomethyl- and the amino group are examples of a group RIRIIN—(CH2)m— wherein the diethylaminomethyl-, piperidinomethyl-, 2-dimethylaminoethyl-, dimethylamino- and the amino group are particularly preferred. Examples of a heteroaryl group are pyrrolidyl, 2-furyl, 2-thienyl, 4-pyridyl, 3-pyridyl, 2-pyridyl, triazolyl and 1-imidazolyl. Examples of a heterocycle (C1-4)alkyl group are pyrrolidino-(C1-4)alkyl, piperidino-(C1-4)alkyl, morpholino-(C1-4)alkyl, 2-furyl-(C1-4) alkyl, 2-thienyl-(C1-4)alkyl, 4-pyridyl-(C1-4)alkyl, 3-pyridyl-(C1-4)alkyl, 2-pyridyl-(C1-4)alkyl, triazolyl-(C1-4)alkyl, and 1-imidazolyl-(C1-4)alkyl. A preferred (C1-4) carboxyalkyl group is the 3-carboxypropyl group. Particularly preferred C2–C6 alkenylene groups are vinylene and propylene. A particularly preferred C4–C6 alkadienylene group is the 1,3-butadien-1,4-diyl group. The groups 1-carboxypropylene and 1-carboxyethylene are preferred carboxy C1–C4 alkylene groups. According to the invention, the subsequently used terms are derived from the definitions given here.
The inventive 1,2-dihydropyrimidinium derivatives according to Formula I are CH-acid compounds. They exist in chemical equilibrium with the enamine form of the 1,2-dihydropyrimidinium derivatives according to Formula I. The corresponding enamines can be specifically synthesized from the compounds of Formula I by the use of a base for deprotonation at the α-carbon atom of the C1–C6 alkyl radical R3 or R4. An example of this deprotonation is illustrated here below, wherein for clarity, the radical R—CH2— was chosen as R3. A compound according to Formula Ia is an example of an inventive enamine form of the 1,2-dihydropyrimidinium derivative.
By keratin-containing fibers should be understood wool, fur, feathers and particularly human hair. In principal however, the inventive colorants can also be used for dyeing other natural fibers such as, for example, cotton, jute, sisal, linen or silk, modified natural fibers such as, for example, regenerated cellulose, nitro-, alkyl- or hydroxyalkyl- or acetyl cellulose.
The majority of 1,2-dihydropyrimidinium derivatives according to Formula I are known from the literature, are commercially available or synthesizable by known synthetic processes according to D. Lloyd et al., J. Chem. Soc. Perkin Trans I, 1977, 16, 1862–1869; S. T. Oswald et al., J. Heterocycl. Chem., 1974, 11(3), 441–443; H. Baumann et al., Liebigs Ann. Chem., 1968, 717, 124–136 and V. A. Chuiguk, Ukr. Khim.Zh. (RussEd.), 1982, 48 (11), 1220–1223.
Colorations with increased brilliance and improved fastness properties (fastness to light, washing fastness, fastness to rubbing) over a broad range of shades are obtained if the compounds of Formula I according to the invention, together with at least one substance with a reactive carbonyl group (subsequently referred to as component B or reactive carbonyl compound) are comprised in the inventive agents. Inventive reactive carbonyl compounds possess at least one carbonyl group as the reactive group that reacts with the CH-acid compound according to Formula I with the formation of a carbon-carbon bond. Moreover, those compounds in which the reactive carbonyl group is derivatized in such a manner that the reactivity of the carbon atom of the derivatized carbonyl group towards the CH-acid compounds of Formula I is still present, are also usable according to the invention. These derivatives are preferably addition compounds of
Component B is preferably selected from compounds according to Formula II,
wherein
wherein
The component B is particularly preferably selected from the group consisting of acetophenone, propiophenone, 2-hydroxyacetophenone, 3-hydroxyacetophenone, 4-hydroxyacetophenone, 2-hydroxypropiophenone, 3-hydroxypropiophenone, 4-hydroxypropiophenone, 2-hydroxybutyrophenone, 3-hydroxybutyrophenone, 4-hydroxybutyrophenone, 2,4-dihydroxyacetophenone, 2,5-dihydroxyacetophenone, 2,6-dihydroxyacetophenone, 2,3,4-trihydroxyacetophenone, 3,4,5-trihydroxyacetophenone, 2,4,6-trihydroxyacetophenone, 2,4,6-trimethoxyacetophenone, 3,4,5-trimethoxyacetophenone, 3,4,5-trimethoxy-acetophenone-diethylketal, 4-hydroxy-3-methoxy-acetophenone, 3,5-dimethoxy-4-hydroxyacetophenone, 4-aminoacetophenone, 4-dimethylaminoacetophenone, 4-morpholinoacetophenone, 4-piperidinoacetophenone, 4-imidazolinoacetophenone, 2-hydroxy-5-bromo-acetophenone, 4-hydroxy-3-nitroacetophenone, acetophenone-2-carboxylic acid, acetophenone-4-carboxylic acid, benzophenone, 4-hydroxybenzophenone, 2-aminobenzophenone, 4,4′-dihydroxybenzophenone, 2,4-dihydroxy-benzophenone, 2,4,4′-trihydroxybenzophenone, 2,3,4-trihydroxybenzophenone, 2-hydroxy-1-acetonaphthone, 1-hydroxy-2-acetonaphthone, chromone, chromone-2-carboxylic acid, flavone, 3-hydroxyflavone, 3,5,7-trihydroxyflavone, 4′,5,7-trihydroxyflavone, 5,6,7-trihydroxyflavone, quercetin, 1-indanone, 9-fluorenone, 3-hydroxyfluorenone, anthrone, 1,8-dihydroxyanthrone, vanillin, coniferyl aldehyde, 2-methoxybenzaldehyde, 3-methoxybenzaldehyde, 4-methoxybenzaldehyde, 2-ethoxybenzaldehyde, 3-ethoxybenzaldehyde, 4-ethoxybenzaldehyde, 4-hydroxy-2,3-dimethoxy-benzaldehyde, 4-hydroxy-2,5-dimethoxy-benzaldehyde, 4-hydroxy-2,6-dimethoxy-benzaldehyde, 4-hydroxy-2-methylbenzaldehyde, 4-hydroxy-3-methyl-benzaldehyde, 4-hydroxy-2,3-dimethylbenzaldehyde, 4-hydroxy-2,5-dimethyl-benzaldehyde, 4-hydroxy-2,6-dimethylbenzaldehyde, 4-hydroxy-3,5-dimethoxy-benzaldehyde, 4-hydroxy-3,5-dimethylbenzaldehyde, 3,5-diethoxy-4-hydroxy-benzaldehyde, 2,6-diethoxy-4-hydroxybenzaldehyde, 3-hydroxy-4-methoxy-benzaldehyde, 2-hydroxy-4-methoxybenzaldehyde, 2-ethoxy-4-hydroxy-benzaldehyde, 3-ethoxy-4-hydroxy-benzaldehyde, 4-ethoxy-2-hydroxy-benzaldehyde, 4-ethoxy-3-hydroxy-benzaldehyde, 2,3-dimethoxybenzaldehyde, 2,4-dimethoxybenzaldehyde, 2,5-dimethoxybenzaldehyde, 2,6-dimethoxybenzaldehyde, 3,4-dimethoxybenzaldehyde, 3,5-dimethoxybenzaldehyde, 2,3,4-trimethoxybenzaldehyde, 2,3,5-trimethoxybenzaldehyde, 2,3,6-trimethoxybenzaldehyde, 2,4,6-trimethoxybenzaldehyde, 2,4,5-trimethoxybenzaldehyde, 2,5,6-trimethoxybenzaldehyde, 2-hydroxybenzaldehyde, 3-hydroxybenzaldehyde, 4-hydroxybenzaldehyde, 2,3-dihydroxybenzaldehyde, 2,4-dihydroxybenzaldehyde, 2,5-dihydroxybenzaldehyde, 2,6-dihydroxybenzaldehyde, 3,4-dihydroxybenzaldehyde, 3,5-dihydroxybenzaldehyde, 2,3,4-trihydroxybenzaldehyde, 2,3,5-trihydroxybenzaldehyde, 2,3,6-trihydroxybenzaldehyde, 2,4,6-trihydroxybenzaldehyde, 2,4,5-trihydroxybenzaldehyde, 2,5,6-trihydroxybenzaldehyde, 4-hydroxy-2-methoxybenzaldehyde, 4-dimethylaminobenzaldehyde, 4-diethylaminobenzaldehyde, 4-dimethylamino-2-hydroxybenzaldehyde, 4-diethylamino-2-hydroxybenzaldehyde, 4-pyrrolidinobenzaldehyde, 4-morpholinobenzaldehyde, 2-morpholinobenzaldehyde, 4-piperidinobenzaldehyde, 2-methoxy-1-naphthaldehyde, 4-methoxy-1-naphthaldehyde, 2-hydroxy-1-naphthaldehyde, 2,4-dihydroxy-1-napthaldehyde, 4-hydroxy-3-methoxy-1-naphthaldehyde, 2-hydroxy-4-methoxy-1-naphthaldehyde, 3-hydroxy-4-methoxy-1-naphthaldehyde, 2,4-dimethoxy-1-naphthaldehyde, 3,4-dimethoxy-1-naphthaldehyde, 4-hydroxy-1-naphthaldehyde, 4-dimethylamino-1-naphthaldehyde, 4-dimethylaminocinnamaldehyde, 2-dimethylaminobenzaldehyde, 2-chloro-4-dimethylaminobenzaldehyde, 4-dimethylamino-2-methylbenzaldehyde, 4-diethylaminocinnamaldehyde, 4-dibutylaminobenzaldehyde, 4-diphenylamino-benzaldehyde, 4-dimethylamino-2-methoxybenzaldehyde, 4-(1-imidazolyl)-benzaldehyde, piperonal, 2,3,6,7-tetrahydro-1H,5H-benzo[ij]quinolizin-9-carboxaldehyde, 2,3,6,7-tetrahydro-8-hydroxy-1H,5H-benzo[ij]quinolizin-9-carboxaldehyde, N-ethylcarbazole-3-aldehyde, 2-formylmethylene-1,3,3-trimethylindoline (Fischer's aldehyde or tribasen aldehyde), 2-indolaldehyde, 3-indolealdehyde, 1-methylindole-3-aldehyde, 2-methylindole-3-aldehyde, 1-acetylindole-3-aldehyde, 3-acetylindole, 1-methyl-3-acetylindole, 2-(1′,3′,3′-trimethyl-2-indolinylidene)acetaldehyde, 1-methylpyrrole-2-aldehyde, 1-methyl-2-acetylpyrrole, 4-pyridinealdehyde, 2-pyridinealdehyde, 3-pyridinealdehyde, 4-acetylpyridine, 2-acetylpyridine, 3-acetylpyridine, pyridoxal, quinoline-3-aldehyde, quinoline-4-aldehyde, antipyrine-4-aldehyde, furfural, 5-nitrofurfural, 2-thenoyl-trifluoroacetone, chromone-3-aldehyde, 3-(5′-nitro-2′-fury)-acrolein, 3-(2′-furyl)-acrolein and imidazole-2-aldehyde, 1,3-diacetylbenzene, 1,4-diacetylbenzene, 1,3,5-triacetylbenzene, 2-benzoyl-acetophenone, 2-(4′-methoxybenzoyl)acetophenone, 2-(2′-furoyl)acetophenone, 2-(2′-pyridoyl)acetophenone and 2-(3′-pyridoyl)acetophenone, benzylidene acetone, 4-hydroxybenzylidene acetone, 2-hydroxybenzylidene acetone, 4-methoxybenzylidene acetone, 4-hydroxy-3-methoxybenzylidene acetone, 4-dimethylaminobenzylidene acetone, 3,4-methylendioxybenzylidene acetone, 4-pyrrolidinobenzylidene acetone, 4-piperidinobenzylidene acetone, 4-morpholinobenzylidene acetone, 4-diethylaminobenzylidene acetone, 3-benzylidene-2,4-pentanedione, 3-(4′-hydroxybenzylidene)-2,4-pentanedione, 3-(4′-dimethylaminobenzylidene)-2,4-pentanedione, 2-benzylidenecyclohexanone, 2-(4′-hydroxybenzylidene)cyclohexanone, 2-(4′-dimethylaminobenzylidene)cyclohexanone, 2-benzylidene-1,3-cyclohexanedione, 2-(4′-hydroxybenzylidene)-1,3-cyclohexanedione, 3-(4′-dimethylaminobenzylidene)-1,3-cyclohexanedione, 2-benzylidene-5,5-dimethyl-1,3-cyclohexanedione, 2-(4′-hydroxybenzylidene)-5,5-dimethyl-1,3-cyclohexanedione, 2-(4′-hydroxy-3-methoxybenzylidene)-5,5-dimethyl-1,3-cyclohexanedione, 2-(4′-dimethylaminobenzylidene)-5,5-dimethyl-1,3-cyclohexanedione, 2-benzylidenecyclopentanone, 2′-(4-hydroxybenzylidene)-cyclopentanone, 2-(4′-dimethylaminobenzylidene)cyclopentanone, 5-(4-dimethylaminophenyl)penta-2,4-dienal, 5-(4-diethylaminophenyl)penta-2,4-dienal, 5-(4-methoxyphenyl)penta-2,4-dienal, 5-(3,4-dimethoxyphenyl)penta-2,4-dienal, 5-(2,4-dimethoxyphenyl)penta-2,4-dienal, 5-(4-piperidinophenyl)penta-2,4-dienal, 5-(4-morpholinophenyl)penta-2,4-dienal, 5-(4-pyrrolidinophenyl)penta-2,4-dienal, 6-(4-dimethylaminophenyl)hexa-3,5-dien-2-one, 6-(4-diethylaminophenyl)hexa-3,5-dien-2-one, 6-(4-methoxyphenyl)hexa-3,5-dien-2-one, 6-(3,4-dimethoxyphenyl)hexa-3,5-dien-2-one, 6-(2,4-dimethoxyphenyl)hexa-3,5-dien-2-one, 6-(4-piperidinophenyl)hexa-3,5-dien-2-one, 6-(4-morpholinophenyl)hexa-3,5-dien-2-one, 6-(4-pyrrolidinophenyl)hexa-3,5-dien-2-one, 5-(4-dimethylamino-1-naphthyl)penta-3,5-dienal, 2-nitrobenzaldehyde, 3-nitrobenzaldehyde, 4-nitrobenzaldehyde, 4-methyl-3-nitrobenzaldehyde, 3-hydroxy-4-nitrobenzaldehyde, 4-hydroxy-3-nitrobenzaldehyde, 5-hydroxy-2-nitrobenzaldehyde, 2-hydroxy-5-nitrobenzaldehyde, 2-hydroxy-3-nitrobenzaldehyde, 2-fluoro-3-nitrobenzaldehyde, 3-methoxy-2-nitrobenzaldehyde, 4-chloro-3-nitrobenzaldehyde, 2-chloro-6-nitrobenzaldehyde, 5-chloro-2-nitrobenzaldehyde, 4-chloro-2-nitrobenzaldehyde, 2,4-dinitrobenzaldehyde, 2,6-dinitrobenzaldehyde, 2-hydroxy-3-methoxy-5-nitrobenzaldehyde, 4,5-dimethoxy-2-nitrobenzaldehyde, 6-nitropiperonal, 2-nitropiperonal, 5-nitrovanillin, 2,5-dinitrosalicylaldehyde, 5-bromo-3-nitrosalicylaldehyde, 3-nitro-4-formylbenzenesulfonic acid, 4-nitro-1-naphthaldehyde, 2-nitrocinnamaldehyde, 3-nitrocinnamaldehyde, 4-nitrocinnamaldehyde, 9-methyl-3-carbazolealdehyde, 9-ethyl-3-carbazolealdehyde, 3-acetylcarbazole, 3,6-diacetyl-9-ethylcarbazole, 3-acetyl-9-methylcarbazole, 1,4-dimethyl-3-carbazole aldehyde, 1,4,9-trimethyl-3-carbazolealdehyde, 4-formyl-1-methylpyridinium-, 2-formyl-1-methylpyridinium-, 4-formyl-1-ethylpyridinium-, 2-formyl-1-ethylpyridinium-, 4-formyl-1-benzylpyridinium-, 2-formyl-1-benzylpyridinium-, 4-formyl-1,2-dimethylpyridinium-, 4-formyl-1,3-dimethylpyridinium-, 4-formyl-1-methylquinolinium-, 2-formyl-1-methylquinolinium-, 4-acetyl-1-methylpyridinium-, 2-acetyl-1-methylpyridinium-, 4-acetyl-1-methylquinolinium-, 5-formyl-1-methylquinolinium-, 6-formyl-1-methylquinolinium-, 7-formyl-1-methylquinolinium-, 8-formyl-1-methylquinolinium-, 5-formyl-1-ethylquinolinium-, 6-formyl-1-ethylquinolinium-, 7-formyl-1-ethylquinolinium-, 8-formyl-1-ethylquinolinium-, 5-formyl-1-benzylquinolinium-, 6-formyl-1-benzylquinolinium-, 7-formyl-1-benzylquinolinium-, 8-formyl-1-benzylquinolinium, 5-formyl-1-allylquinolinium-, 6-formyl-1-allylquinolinium-, 7-formyl-1-allylquinolinium- and 8-formyl-1-allylquinolinium-, 5-acetyl-1-methylquinolinium-, 6-acetyl-1-methylquinolinium-, 7-acetyl-1-methylquinolinium-, 8-acetyl-1-methylquinolinium, 5-acetyl-1-ethylquinolinium-, 6-acetyl-1-ethylquinolinium-, 7-acetyl-1-ethylquinolinium-, 8-acetyl-1-ethylquinolinium, 5-acetyl-1-benzylquinolinium-, 6-acetyl-1-benzylquinolinium-, 7-acetyl-1-benzylquinolinium-8-acetyl-1-benzylquinolinium-, 5-acetyl-1-allylquinolinium-, 6-acetyl-1-allylquinolinium-, 7-acetyl-1-allylquinolinium- and 8-acetyl-1-allylquinolinium-, 9-formyl-10-methylacridinium-, 4-(2′-formylvinyl)-1-methylpyridinium-, 1,3-dimethyl-2-(4′-formylphenyl)benzimidazolium-, 1,3-dimethyl-2-(4′-formylphenyl)imidazolium-, 2-(4′-formylphenyl)-3-methylbenzothiazolium-, 2-(4′-acetylphenyl)-3-methylbenzothiazolium-, 2-(4′-formylphenyl)-3-methylbenzoxazolium-, 2-(5′-formyl-2′-furyl)-3-methylbenzothiazolium-, 2-(5′-formyl-2′-furyl)-3-methylbenzothiazolium-, 2-(5′-formyl-2′-thienyl)-3-methylbenzothiazolium-, 2-(3′-formylphenyl)-3-methylbenzothiazolium-, 2-(4′-formyl-1-naphthyl)-3-methylbenzothiazolium-, 5-chloro-2-(4′-formylphenyl)-3-methylbenzothiazolium-, 2-(4′-formylphenyl)-3,5-dimethylbenzothiazolium benzenesulfonate, -p-toluenesulfonate, methanesulfonate, -perchlorate, -sulfate, -chloride, -bromide, -iodide, tetrachlorozincate, -methylsulfate-, -trifluoromethansulfonate, -tetrafluoroborate, isatin, 1-methyl-isatin, 1-allyl-isatin, 1-hydroxymethyl-isatin, 5-chloro-isatin, 5-methoxy-isatin, 5-nitroisatin, 6-nitroisatin, 5-sulfoisatin, 5-carboxyisatin, quinisatin, 1-methylquinisatin, together with any mixtures of the above compounds.
In a special embodiment, it can be advantageous to select the component B in such a manner that the group Y of Formula II is not a carbonyl group. In this case, it can be advantageous to select the component B from 2-{[(2-hydroxyethyl)imino]methyl}phenol, 3-{[(2-hydroxyethyl)imino]methyl}phenol, 4-{[(2-hydroxyethyl)imino]methyl}phenol, 3-{[(2-hydroxyethyl)imino]methyl}benzene-1,2-diol, 4-{[(2-hydroxyethyl)imino]methyl}benzene-1,3-diol, 2-{[(2-hydroxyethyl)imino]methyl}benzene-1,4-diol, 2-{[(2-hydroxyethyl)imino]methyl}benzene-1,3-diol, 4-{[(2-hydroxyethyl)imino]methyl}benzene-1,2-diol, 5-{[(2-hydroxyethyl)imino]methyl}benzene-1,3-diol, 4-{[(2-hydroxyethyl)imino]methyl}benzene-1,2,3-triol, 6-{[(2-hydroxyethyl) imino]methyl}benzene-1,2,4-triol, 3-{[(2-hydroxyethyl)imino]methyl}benzene-1,2,4-triol, 2-{[(2-hydroxyethyl)imino]methyl}benzene-1,3,5-triol, 5-{[(2-hydroxyethyl)imino]methyl}benzene-1,2,4-triol, 3-{[(2-hydroxyethyl)imino]methyl}benzene-1,2,4-triol, 2-{[(2-methoxyphenyl) methylene]amino}ethanol, 2-{[(3-methoxyphenyl)methylene]amino}ethanol, 2-{[(4-methoxyphenyl)methylene]amino}ethanol, 2-{[(2-ethoxyphenyl)methylene]amino}ethanol, 2-{[(3-ethoxyphenyl)methylene]amino}ethanol, 2-{[(4-ethoxyphenyl)-methylene]amino}ethanol, 2-{[(2,3-dimethoxyphenyl)methylene]amino}ethanol, 2-{[(2,4-dimethoxyphenyl)methylene]amino}ethanol, 2-[[(2,5-dimethoxyphenyl)methylene]amino}ethanol, 2-{[(2,6-dimethoxyphenyl)methylene]amino}ethanol, 2-{[(2,4-dimethoxyphenyl) methylene]amino}ethanol, 2-{[(3,5-dimethoxyphenyl)methylene]amino}ethanol, 2-{[(2,3,4-trimethoxyphenyl)methylene]amino}ethanol, 2{[(2,3,5-trimethoxyphenyl)methylene]amino}ethanol, 2-{[(2,3,6-trimethoxyphenyl)methylene]amino}ethanol, 2-{[(2,4,6-trimethoxyphenyl)methylene]amino}ethanol, 2-{[(2,4,5-trimethoxyphenyl)methylene]amino}ethanol, 2-{[(2,3,6-trimethoxyphenyl)methylene]amino}ethanol, 4-{[(2-hydroxyethyl)imino]methyl}-3-methoxyphenol, 4-{[(2-hydroxyethyl)imino]methyl}-2-methoxyphenol, 5-{[(2-hydroxyethyl)imino]methyl}-2-methoxyphenol, 2-{[(2-hydroxyethyl)imino]methyl}-5-methoxyphenol, 3-ethoxy-4-{[(2-hydroxyethyl)imino]methyl}phenol, 2-ethoxy-4-{[(2-hydroxyethyl)imino]methyl}phenol, 5-ethoxy-2-{[(2-hydroxyethyl)imino]methyl}phenol, 2-ethoxy-5-{[(2-hydroxyethyl)imino]methyl}phenol, 4-{[(2-hydroxyethyl)imino]methyl}-2,3-dimethoxyphenol, 4-{[(2-hydroxyethyl)imino]methyl}-2,5-dimethoxyphenol, 4-{[(2-hydroxyethyl)imino]methyl}-3,5-dimethoxyphenol, 4-{[(2-hydroxyethyl)imino]methyl}-2,6-dimethoxyphenol, 2,6-diethoxy-4-{[(2-hydroxyethyl)imino]methyl}phenol, 3,5-diethoxy-4-{[(2-hydroxyethyl)imino]methyl}phenol, 4-{[(2-hydroxyethyl)imino]methyl}-3-methylphenol, 4-{[(2-hydroxyethyl)imino]methyl}-2-methylphenol, 4-{[(2-hydroxyethyl)imino]methyl}-2,3-dimethylphenol, dimethylphenol, 4-{[(2-hydroxyethyl)imino]methyl}-2,5-dimethylphenol, 4-{[(2-hydroxyethyl)imino]methyl}-3,5-dimethylphenol, 4-{[(2-hydroxyethyl)imino]methyl}-2,6-dimethylphenol, 2-({[4-(dibutylamino)phenyl]methylene}amino)ethanol, 2-({[2-chloro-4-(dimethylamino)phenyl]methylene}amino)ethanol, 2-({[4-(dimethylamino)-2-methylphenyl]methylene}amino)ethanol, 2-({[4-(dimethylamino)-2-methoxyphenyl]methylene}amino)ethanol, 2-({[2-(dimethylamino)phenyl]methylene}amino)ethanol, 2-({[4-(dimethylamino)phenyl]methylene}amino)ethanol, 2-({[4-(diethylamino)phenyl]methylene}amino)ethanol, 5-(dimethylamino)-2-{[(2-hydroxyethyl)imino]methyl}phenol, 5-(diethylamino)-2-{[(2-hydroxyethyl)imino]methyl}phenol, 2-{[(4-pyrrolidin-1-ylphenyl)methylene]amino}ethanol, 2-{[(4-piperidin-1-ylphenyl)methylene]amino}ethanol, 2-{[(4-morpholin-4-ylphenyl)methylene]amino}ethanol, 2-{[(2-morpholin-4-ylphenyl)methylene]amino}ethanol, 2-{[(2-methoxy-1-naphthyl)methylene]amino}ethanol, 2-{[(4-methoxy-1-naphthyl)methylene]amino}ethanol, 1-{[(2-hydroxyethyl)imino]methyl}-2-naphthol, 4-{[(2-hydroxyethyl)imino]methyl}-1-naphthol, 4-{[(2-hydroxyethyl)imino]methyl}naphthalene-1,3-diol, 4-{[(2-hydroxyethyl)imino]methyl}-2-methoxy-1-naphthol, 1-{[(2-hydroxyethyl)imino]methyl}-2-methoxy-2-naphthol, 4-{[(2-hydroxyethyl)imino]methyl}-1-methoxy-2-naphthol, 2-{[(2,4-dimethoxy-1-naphthyl)methylene]amino}ethanol, 2-{[(3,4-dimethoxy-1-naphthyl)methylene]amino}ethanol, 2-({[4-(dimethylamino)-1-naphthyl]methylene}amino)ethanol, 2-({3-[4-(dimethylamino)phenyl]prop-2-enylidene}amino)ethanol, 2-({3-[4-(diethylamino)phenyl)prop-2-enylidene)amino)ethanol, 4-{3-[(2-hydroxyethyl)-imino]prop-1-enyl}-2-methoxyphenol, 2-(diethoxymethyl)phenol, 3-(diethoxymethyl)phenol, 4-(diethoxymethyl)phenol, 3-(diethoxymethyl)benzene-1,2-diol, 4-(diethoxymethyl)benzene-1,3-diol, 2-(diethoxymethyl)benzene-1,4-diol, 2-(diethoxymethyl)-benzene-1,3-diol, 4-(diethoxymethyl)benzene-1,2-diol, 5-(diethoxymethyl)benzene-1,3-diol, 4-(diethoxymethyl)benzene-1,2,3-triol, 6-(diethoxymethyl)benzene-1,2,4-triol, 3-(diethoxymethyl)benzene-1,2,4-triol, 2-(diethoxymethyl)benzene-1,3,5-triol, 5-(diethoxymethyl)benzene-1,2,4-triol, 3-(diethoxymethyl)benzene-1,2,4-triol, 1-(diethoxymethyl)-2-methoxybenzene, 1-(diethoxymethyl)-3-methoxybenzene, 1-(diethoxymethyl)-4-methoxybenzene, 1-(diethoxymethyl)-2-ethoxybenzene, 1-(diethoxymethyl)-3-ethoxybenzene, 1-(diethoxymethyl)-4-ethoxybenzene, 1-(diethoxymethyl)-2,3-dimethoxybenzene, 1-(diethoxymethyl)-2,4-dimethoxybenzene, 2-(diethoxymethyl)-1,4-dimethoxybenzene, 2-(diethoxymethyl)-1,3-dimethoxybenzene, 4-(diethoxymethyl)-1,2-dimethoxybenzene, 1-(diethoxymethyl)-3,5-dimethoxybenzene, 1-(diethoxymethyl)-2,3,4-trimethoxybenzene, 1-(diethoxymethyl)-2,3,5-trimethoxybenzene, 2-(diethoxymethyl)-1,3,4-trimethoxybenzene, 2-(diethoxymethyl)-1,3,5-trimethoxybenzene, 1-(diethoxymethyl)-2,4,5-trimethoxybenzene, 2-(diethoxymethyl)-1,3,4-trimethoxybenzene, 4-(diethoxymethyl)-3-methoxyphenol, 4-(diethoxymethyl)-2-methoxyphenol, 5-(diethoxymethyl)-2-methoxyphenol, 2-(diethoxymethyl)-5-methoxyphenol, 4-(diethoxymethyl)-3-ethoxyphenol, 4-(diethoxymethyl)-2-ethoxyphenol, 2-(diethoxymethyl)-5-ethoxyphenol, 5-(diethoxymethyl)-2-ethoxyphenol, 4-(diethoxymethyl)-2,3-dimethoxyphenol, 4-(diethoxymethyl)-2,5-dimethoxyphenol, 4-(diethoxymethyl)-3,5-dimethoxyphenol, 4-(diethoxymethyl)-2,6-dimethoxyphenol, 4-(diethoxymethyl)-2,6-diethoxyphenol, 4-(diethoxymethyl)-3,5-diethoxyphenol, 4-(diethoxymethyl)-3-methylphenol, 4-(diethoxymethyl)-2-methylphenol, 4-(diethoxymethyl)-2,3-dimethylphenol, 4-(diethoxymethyl)-2,5-dimethylphenol, 4-(diethoxymethyl)-3,5-dimethylphenol, 4-(diethoxymethyl)-2,6-dimethylphenol, N-[4-(diethoxymethyl)phenyl]-N,N-dibutylamine, N-[3-chloro-4-(diethoxymethyl)phenyl]-N,N-dimethylamine, N-[4-(diethoxymethyl)-3-methylphenyl]-N,N-dimethylamine, N-[4-(diethoxymethyl)-3-methoxyphenyl]-N,N-dimethylamine, N-[2-(diethoxymethyl)phenyl]-N,N-dimethylamine, N-[4-(diethoxymethyl)phenyl]-N,N-dimethylamine, N-[4-(diethoxymethyl)phenyl]-N,N-diethylamine, 2-(diethoxymethyl)-5-(dimethylamino)phenol, 2-(diethoxymethyl)-5-(diethylamino)phenol, 1-[4-(diethoxymethyl)phenyl]pyrrolidine, 1-[4-(diethoxymethyl)phenyl]piperidine, 4-[4-(diethoxymethyl)phenyl]morpholine, 4-[2-(diethoxymethyl)phenyl]morpholine, 1-(diethoxymethyl)-2-methoxynaphthalene, 1-(diethoxymethyl)4-methoxynaphthalene, 1-(diethoxymethyl)-2-naphthol, 4-(diethoxymethyl)-1-naphthol, 4-(diethoxymethyl)-naphthalene-1,3-diol, 4-(diethoxymethyl)-2-methoxy-1-naphthol, 1-(diethoxymethyl)-4-methoxy-2-naphthol, 4-(diethoxymethyl)-1-methoxy-2-naphthol, 1-(diethoxymethyl)-2,4-dimethoxynaphthalene, 4-(diethoxymethyl)-1,2-dimethoxynaphthalene, N-[4-(diethoxymethyl)-1-naphthyl]-N,N-dimethylamine, N-{4-[3,3-diethoxyprop-1-enyl]phenyl}-N,N-dimethylamine, N-{4-[3,3-diethoxyprop-1-enyl]phenyl}-N,N-diethylamine and 4-(3,3-diethoxyprop-1-enyl)-2-methoxyphenol.
Benzaldehyde, cinnamic aldehyde and naphthaldehyde, as well as their derivatives, particularly with one or more hydroxyl, alkoxy and amino substituents, are quite particularly preferred for use as component B. Here again the compounds according to Formula V are preferred,
in which
Quite particularly preferred compounds for component B are selected from the group consisting of vanillin, coniferyl aldehyde, 2-methoxybenzaldehyde, 3-methoxybenzaldehyde, 4-methoxybenzaldehyde, 2-ethoxybenzaldehyde, 3-ethoxybenzaldehyde, 4-ethoxybenzaldehyde, 4-hydroxy-2,3-dimethoxy-benzaldehyde, 4-hydroxy-2,5-dimethoxybenzaldehyde, 4-hydroxy-2,6-dimethoxybenzaldehyde, 4-hydroxy-2-methylbenzaldehyde, 4-hydroxy-3-methylbenzaldehyde, 4-hydroxy-2,3-dimethylbenzaldehyde, 4-hydroxy-2,5-dimethylbenzaldehyde, 4-hydroxy-2,6-dimethylbenzaldehyde, 4-hydroxy-3,5-dimethoxybenzaldehyde, 4-hydroxy-3,5-dimethylbenzaldehyde, 3,5-diethoxy-4-hydroxybenzaldehyde, 2,6-diethoxy-4-hydroxybenzaldehyde, 3-hydroxy-4-methoxybenzaldehyde, 2-hydroxy-4-methoxybenzaldehyde, 2-ethoxy-4-hydroxybenzaldehyde, 3-ethoxy-4-hydroxybenzaldehyde, 4-ethoxy-2-hydroxy-benzaldehyde, 4-ethoxy-3-hydroxybenzaldehyde, 2,3-dimethoxybenzaldehyde, 2,4-dimethoxybenzaldehyde, 2,5-dimethoxybenzaldehyde, 2,6-dimethoxybenzaldehyde, 3,4-dimethoxybenzaldehyde, 3,5-dimethoxybenzaldehyde, 2,3,4-trimethoxybenzaldehyde, 2,3,5-trimethoxybenzaldehyde, 2,3,6-trimethoxybenzaldehyde, 2,4,6-trimethoxybenzaldehyde, 2,4,5-trimethoxybenzaldehyde, 2,5,6-trimethoxybenzaldehyde, 2-hydroxybenzaldehyde, 3-hydroxybenzaldehyde, 4-hydroxybenzaldehyde, 2,3-dihydroxybenzaldehyde, 2,4-dihydroxybenzaldehyde, 2,5-dihydroxybenzaldehyde, 2,6-dihydroxybenzaldehyde, 3,4-dihydroxybenzaldehyde, 3,5-dihydroxybenzaldehyde, 2,3,4-trihydroxybenzaldehyde, 2,3,5-trihydroxybenzaldehyde, 2,3,6-trihydroxybenzaldehyde, 2,4,6-trihydroxybenzaldehyde, 2,4,5-trihydroxybenzaldehyde, 2,5,6-trihydroxybenzaldehyde, 4-hydroxy-2-methoxybenzaldehyde, 4-dimethylaminobenzaldehyde, 4-diethylaminobenzaldehyde, 4-dimethylamino-2-hydroxybenzaldehyde, 4-diethylamino-2-hydroxybenzaldehyde, 4-pyrrolidinobenzaldehyde, 4-morpholinobenzaldehyde, 2-morpholinobenzaldehyde, 4-piperidinobenzaldehyde, 2-methoxy-1-naphthaldehyde, 4-methoxy-1-naphthaldehyde, 2-hydroxy-1-naphthaldehyde, 2,4-dihydroxy-1-napthaldehyde, 4-hydroxy-3-methoxy-1-naphthaldehyde, 2-hydroxy-4-methoxy-1-naphthaldehyde, 3-hydroxy-4-methoxy-1-naphthaldehyde, 2,4-dimethoxy-1-naphthaldehyde, 3,4-dimethoxy-1-naphthaldehyde, 4-hydroxy-1-naphthaldehyde, 4-dimethylamino-1-naphthaldehyde, 4-dimethylaminocinnamaldehyde, 2-dimethylaminobenzaldehyde, 2-chloro-4-dimethylaminobenzaldehyde, 4-dimethylamino-2-methylbenzaldehyde, 4-diethylaminocinnamaldehyde, 4-dibutylaminobenzaldehyde, 4-diphenylamino-benzaldehyde, 4-dimethylamino-2-methoxybenzaldehyde, 4-(1-imidazolyl)-benzaldehyde and piperonal.
In a second embodiment, it can be advantageous to broaden the color spectrum and improve the fastness properties by adding to the inventive agent besides at least one compound according to Formula I and at least one reactive carbonyl compound (component B), at least a further compound as component C, selected from (a) CH-acid compounds and (b) compounds with primary or secondary amino or hydroxyl groups, selected from aromatic hydroxyl compounds, primary or secondary aromatic amines and nitrogen-containing heterocyclic compounds.
The CH-acid compounds of the component C are selected from the group consisting of 1,2,3,3-tetramethyl-3H-indolium iodide, 1,2,3,3-tetramethyl-3H-indolium p-toluenesulfonate, 1,2,3,3-tetramethyl-3H-indolium methanesulfonate, 1,3,3-trimethyl-2-methyleneindoline (Fischer Base), 2,3-dimethyl-benzothiazolium iodide, 2,3-dimethylbenzothiazolium p-toluenesulfonate, 2,3-dimethyl-naphtho[1,2-d]thiazolium p-toluenesulfonate, 3-ethyl-2-methyl-naphtho[1,2-d]thiazolium p-toluenesulfonate, rhodanine,rhodanine-3-acetic acid, 1,4-dimethylquinolinium iodide, 1,2-dimethylquinolinium iodide, barbituric acid, thiobarbituric acid, 1,3-dimethylthiobarbituric acid, 1,3-diethylthiobarbituric acid, 1,3-diethylbarbituric acid, oxindole, 3-indoxy]acetate, 2-coumaranone, 5-hydroxy-2-coumaranone, 6-hydroxy-2-coumaranone, 3-methyl-1-phenyl-pyrazolin-5-one, indane-1,2-dione, indane-1,3-dione, indan-1-one, benzoylacetonitrile, 3-dicyanomethyleneindan-1-one, 2-amino-4-imino-1,3-thiazoline hydrochloride, 5,5-dimethylcyclohexane-1,3-dione, 2H-1,4-benzoxazine-4H-3-one, 3-ethyl-2-methyl-benzoxazolium iodide, 3-ethyl-2-methylbenzothiazolium iodide, 1-ethyl-4-methylquinolinium iodide, 1-ethyl-2-methylquinolinium iodide, 1,2,3-trimethylquinoxalinium iodide, 3-ethyl-2-methylbenzoxazolium p-toluenesulfonate, 3-ethyl-2-methyl-benzothiazolium p-toluenesulfonate, 1-ethyl-4-methyl-quinolinium p-toluenesulfonate, 1-ethyl-2-methylquinolinium p-toluenesulfonate, and 1,2,3-trimethylquinoxalinium p-toluenesulfonate.
The primary and secondary aromatic amines of the component C are preferably selected from the group consisting of N,N-dimethyl-p-phenylenediamine, N,N-diethyl-p-phenylenediamine, N-(2-hydroxyethyl)-N-ethyl-p-phenylenediamine, N,N-bis-(2-hydroxyethyl)-p-phenylenediamine, N-(2-methoxyethyl)-p-phenylenediamine, 2,3-dichloro-p-phenylenediamine, 2,4-dichloro-p-phenylenediamine, 2,5-dichloro-p-phenylenediamine, 2-chloro-p-phenylenediamine, 2,5-dihydroxy-4-morpholinoaniline, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminomethyl-4-aminophenol, 2-hydroxymethyl-4-aminophenol, o-phenylenediamine, m-phenylenediamine, p-phenylenediamine, 2,5-diaminotoluene, 2,5-diaminophenol, 2,5-diaminoanisole, 2,5-diaminophenethol, 4-amino-3-methylphenol, 2-(2,5-diaminophenyl)ethanol, 2,4-diaminophenoxyethanol, 2-(2,5-diaminophenoxy)ethanol, 3-amino-4-(2-hydroxyethyloxy)phenol, 3,4-methylenedioxyphenol, 3,4-methylenedioxyaniline, 3-amino-2,4-dichlorophenol, 4-methylaminophenol, 2-methyl-5-aminophenol, 3-methyl-4-aminophenol, 2-methyl-5-(2-hydroxyethylamino)phenol, 3-amino-2-chloro-6-methylphenol, 2-methyl-5-amino-4-chlorophenol, 5-(2-hydroxyethylamino)4-methoxy-2-methylphenol, 4-amino-2-hydroxymethylphenol, 2-(diethylaminomethyl)4-aminophenol, 4-amino-1-hydroxy-2-(2-hydroxyethylaminomethyl)benzene, 1-hydroxy-2-amino-5-methyl-benzene, 1-hydroxy-2-amino-6-methyl-benzene, 2-amino-5-acetamidophenol, 1,3-dimethyl-2,5-diaminobenzene, 5-(3-hydroxypropylamino)-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, N,N-dimethyl-3-aminophenol, N-cyclopentyl-3-aminophenol, 5-amino-4-fluoro-2-methylphenol, 2,4-diamino-5-fluorotoluene, 2,4-diamino-5-(2-hydroxyethoxy)-toluene, 2,4-diamino-5-methylphenetol, 3,5-diamino-2-methoxy-1-methylbenzene, 2-amino-4-(2-hydroxyethylamino)anisole, 2,6-bis-(2-hydroxyethylamino)-1-methylbenzene, 1,3-diamino-2,4-dimethoxybenzene, 3,5-diamino-2-methoxy-toluene, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 2-aminophenylacetic acid, 3-aminophenylacetic acid, 4-aminophenylacetic acid, 2,3-diaminobenzoic acid, 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,4-diaminobenzoic acid, 3,5-diaminobenzoic acid, 4-aminosalicylic acid, 5-aminosalicylic acid, 3-amino-4-hydroxybenzoic acid, 4-amino-3-hydroxybenzoic acid, 2-aminobenzenesulfonic acid, 3-aminobenzenesulfonic acid, 4-aminobenzenesulfonic acid, 3-amino-4-hydroxybenzenesulfonic acid, 4-amino-3-hydroxynaphthalene-1-sulfonic acid, 6-amino-7-hydroxynaphthalene-2-sulfonic acid, 7-amino-4-hydroxynaphthalene-2-sulfonic acid, 4-amino-5-hydroxynaphthalene-2,7-disulfonic acid, 3-amino-2-naphthoic acid, 3-aminophthalic acid, 5-aminoisophthalic acid, 1,3,5-triaminobenzene, 1,2,4-triaminobenzene, 1,2,4,5-tetraminobenzene, 2,4,5-triaminophenol; pentaminobenzene, hexaminobenzene, 2,4,6-triaminoresorcine, 4,5-diaminopyrocatechol, 4,6-diaminopyrogallol, 1-(2-hydroxy-5-aminobenzyl)-2-imidazolidinone, 4-amino-2((4-[(5-amino-2-hydroxyphenyl)methyl]-piperazinyl)methyl)phenol, 3,5-diamino-4-hydroxypyrocatechol, 1,4-bis-(4-aminophenyl)-1,4-diazacycloheptane, aromatic nitriles, such as 2-amino-4-hydroxybenzonitrile, 4-amino-2-hydroxybenzonitrile, 4-aminobenzonitrile, 2,4-diaminobenzonitrile, amino compounds with nitro groups, such as 3-amino-6-methylamino-2-nitropyridine, picramic acid, [8-[(4-amino-2-nitrophenyl)-azo]-7-hydroxy-naphth-2-yl]trimethylammonium chloride, [8-[(4-amino-3-nitrophenyl)-azo)-7-hydroxy-naphth-2-yl]trimethylammonium chloride (Basic Brown 17), 1-hydroxy-2-amino-4,6-dinitrobenzene, 1-amino-2-nitro-4-[bis(2-hydroxyethyl)amino]benzene, 1-amino-2-[(2-hydroxyethyl)amino]-5-nitrobenzene (HC Yellow Nr. 5), 1-amino-2-nitro-4-[(2-hydroxyethyl)amino]benzene (HC Red Nr. 7), 2-chloro-5-nitro-N-2-hydroxyethyl-1,4-phenylenediamine, 1-[(2-hydroxyethyl)amino]-2-nitro-4-aminobenzene (HC Red Nr. 3), 4-amino-3-nitrophenol, 4-amino-2-nitrophenol, 6-nitro-o-toluidine, 1-amino-3-methyl-4-[(2-hydroxyethyl)amino]-6-nitrobenzene (HC Violet Nr. 1), 1-amino-2-nitro-4-[(2,3-dihydroxypropyl)amino]-5-chlorobenzene (HC Red Nr. 10), 2-(4-amino-2-nitroanilino)benzoic acid, 6-nitro-2,5-diaminopyridine, 2-amino-6-chloro-4-nitrophenol, disodium salt of 1-amino-2-(3-nitrophenylazo)-7-phenylazo-8-naphthol-3,6-disulfonic acid (acid blue Nr.29), disodium salt of 1-amino-2-(2-hydroxy-4-nitrophenylazo)-8-naphthol-3,6-disulfonic acid (Palatinchrome green), disodium salt of 1-amino-2-(3-chloro-2-hydroxy-5-nitrophenylazo)-8-naphthol-3,6-disulfonic acid (Gallion), disodium salt of 4-amino-4′-nitrostilbene-2,2′-disulfonic acid, 2,4-diamino-3′,5′-dinitro-2′-hydroxy-5-methylazobenzene (Mordant brown 4), 4′-amino-4-nitrodiphenylamine-2-sulfonic acid, 4′-amino-3′-nitrobenzophenone-2-carboxylic acid, 1-amino-4-nitro-2-(2-nitrobenzylideneamino)benzene, 2-[2-(diethylamino)ethylamino]-5-nitroaniline, 3-amino-4-hydroxy-5-nitrobenzenesulfonic acid, 3-amino-3′-nitrobiphenyl, 3-amino-4-nitroacenaphthene, 2-amino-1-nitronaphthalene, 5-amino-6-nitrobenzo-1,3-dioxol, anilines, particularly anilines containing nitro groups, such as 4-nitroaniline, 2-nitroaniline, 1,4-diamino-2-nitrobenzene, 1,2-diamino-4-nitrobenzene, 1-amino-2-methyl-6-nitrobenzene, 4-nitro-1,3-phenylenediamine, 2-nitro-4-amino-1-(2-hydroxyethylamino)benzene, 2-nitro-1-amino-4-[bis(2-hydroxyethyl)amino]benzene, 4-amino-2-nitrodiphenylamine-2′-carboxylic acid, 1-amino-5-chloro-4-(2-hydroxyethylamino)-2-nitrobenzene, aromatic anilines or phenols with a further aromatic radical, as illustrated in Formula VI
in which
The nitrogen-containing heterocyclic compounds of the component C are preferably selected from the group consisting of 2-aminopyridine, 3-aminopyridine, 4-aminopyridine, 2-amino-3-hydroxypyridine, 2,6-diaminopyridine, 2,5-diaminopyridine, 2-(aminoethylamino)-5-aminopyridine, 2,3-diaminopyridine, 2-dimethylamino-5-aminopyridine, 2-methylamino-3-amino-6-methoxypyridine, 2,3-diamino-6-methoxypyridine, 2,6-dimethoxy-3,5-diaminopyridine, 2,4,5-triaminopyridine, 2,6-dihydroxy-3,4-dimethylpyridine, N-[2-(2,4-diaminophenyl)aminoethyl]-N-(5-amino-2-pyridyl)amine, N-[2-(4-aminophenyl)aminoethyl]-N-(5-amino-2-pyridyl)amine, 2,4-dihydroxy-5,6-diaminopyrimidine, 4,5,6-triaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2,4,5,6-tetraminopyrimidine, 2-methylamino-4,5,6-triaminopyrimidine, 2,4-diaminopyrimidine, 4,5-diaminopyrimidine, 2-amino-4-methoxy-6-methyl-pyrimidine, 3,5-diaminopyrazole, 3,5-diamino-1,2,4-triazole, 3-aminopyrazole, 3-amino-5-hydroxypyrazole, 1-phenyl-4,5-diaminopyrazole, 1-(2-hydroxyethyl)-4,5-diaminopyrazole, 1-phenyl-3-methyl-4,5-diaminopyrazole, 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (4-aminoantipyrine), 1-phenyl-3-methylpyrazol-5-one, 2-aminoquinoline, 3-aminoquinoline, 8-aminoquinoline, 4-aminoquinaldine, 2-aminonicotinic acid, 6-aminonicotinic acid, 5-aminoisoquinoline, 5-aminoindazole, 6-aminoindazole, 5-aminobenzimidazole, 7-aminobenzimidazole, 5-aminobenzothiazole, 7-aminobenzothiazole, 2,5-dihydroxy-4-morpholino-aniline as well as indole- and indoline derivatives, such as 4-aminoindole, 5-aminoindole, 6-aminoindole, 7-aminoindole, 5,6-dihydroxyindole, 5,6-dihydroxyindoline, 4-hydroxyindoline. Further heterocyclic compounds that can be used according to the invention are the hydroxypyrimidines disclosed in DE-U1-299 08 573. The above named compounds can be used both in their free form and in the form of their physiologically compatible salts, e.g. as salts of inorganic acids, such as hydrochloric or sulfuric acid.
The aromatic hydroxyl compounds of the component C are preferably selected from the group consisting of 2-, 4-, 5-methylresorcinol, 2,5-dimethylresorcinol, resorcinol, 3-methoxyphenol, pyrocatechol, hydroquinone, pyrogallol, phloroglucine, hydroxyhydroquinone, 2-, 3-, 4-methoxy-, 3-dimethylamino-, 2-(2-hydroxyethyl)-, 3,4-methylenedioxyphenol, 2,4-, 3,4-dihydroxybenzoic acid, -phenylacetic acid, gallic acid, 2,4,6-trihydroxybenzoic acid, -acetophenone, 2-, 4-chlororesorcinol, 1-naphthol, 1,5-, 2,3-, 2,7-dihydroxynaphthalene, 6-dimethylamino-4-hydroxy-2-naphthalenesulfonic acid and 3,6-dihydroxy-2,7-naphthalenesulfonic acid.
Hair dyes that inter alia comprise at least one compound with a 1,2-dihydropyrimidinium radical as the substantive dyestuff are known to the person skilled in the art from the printed publications EP-A2-998 908 and JP-A2-2002047153. In a third embodiment the dye comprises at least one reaction product (subsequently called reaction product RP) from a 1,2-dihydropyrimidinium derivative of Formula I and a compound of component B, particularly compounds according to Formula II, as the substantive dyestuff. Such reaction products RP can be obtained by e.g. heating both reaction partners in an aqueous, neutral to weakly alkaline medium, whereby the reaction products RP either precipitate out as a solid from the solution or are isolated therefrom by evaporating the solution. There is also the possibility of synthesizing the reaction products according to the literature H. Baumann et al., J. Liebigs Ann. Chem., 1968, 717, 124–136 or DE-A1-2165913.
Consequently, the inventive agents can comprise reaction products RP according to the Formula VIII,
in which
in which
Molar ratios of component B to the compound according to Formula I can be expediently from about 1:1 to about 2.1 for the synthesis of the reaction product RP. For a 1,2-dihydropyrimidinium derivative according to Formula I when only one substituent R23 or R24 differs from hydrogen, then about 1 mole-equivalent of component B is reacted with one mole-equivalent 1,2-dihydropyrimidinium derivative. In this case, either R23 or R24 in Formula VIII stands for a hydrogen atom and the other radical for a group according to Formula IX. If both substituents R3 and R4 in Formula I are different from a hydrogen atom, then these 1,2-dihydropyrimidinium derivatives can be reacted with both about one and about two mole-equivalents of component B. In the last case, both radicals R23 and R24 in the resulting reaction products RP stand for a group according to Formula IX.
It is particularly preferred if the inventive agent comprise such reaction products RP according to Formula VIII, in which AR, according to Formula IX stands for benzene or naphthalene.
It is further particularly preferred if the inventive agent comprises such reaction products RP according to Formula VIII, in which Z, according to Formula IX stands for a direct bond or vinylene.
It is particularly preferred if the inventive agent comprises such reaction products RP according to Formula. VIII, in which R25, according to Formula IX stands for a hydrogen atom.
It is particularly preferred if the inventive agent comprises such reaction products RP according to Formula VIII, in which R6, according to Formula IX stands for a hydrogen atom.
It is particularly preferred if the inventive agent comprises such reaction products RP according to Formula VIII, in which R7, R8 and R9, according to Formula IX stand, independently of one another for a hydrogen atom, a halogen atom, a C1–C6 alkyl group, a hydroxyl group, a C1–C6 alkoxy group, an amino group, a C1–C6 dialkylamino group, a di(C2–C6 hydroxyalkyl)amino group, a di(C1–C6 alkoxy-C1–C6-alkyl)amino group, a C1–C6 hydroxyalkyloxy group, a sulfonyl group, a carboxyl group, a sulfonamide group, a carbamoyl group, a C2–C6 acyl group, an acetyl group, a sulfonic acid group, a sulfonamide group or a nitro group.
It is particularly preferred if the inventive agent comprises such reaction products RP according to Formula VIII, in which R7, R8 and R9, according to Formula IX stand, independently of one another for a hydrogen atom, a halogen atom, a C1–C6 alkyl group, a hydroxyl group, a C1–C6 alkoxy group, an amino group, a C1–C6 dialkylamino group, a di(C2–C6 hydroxyalkyl)amino group, a di(C1–C6 alkoxy-C1–C6-alkyl)amino group, a C1–C6 hydroxyalkyloxy group, a sulfonyl group, a carboxyl group, a sulfonamide group, a carbamoyl group, a C2–C6 acyl group, an acetyl group, a sulfonic acid group, a sulfonamide group or a nitro group, with the proviso that if AR stands for benzene and one of the radicals R7, R8 or R9, para to group Z stands for a hydrogen atom, a halogen atom, a C1–C6 alkoxy group or an amino group, then both the other radicals independently of one another mean neither a hydrogen atom nor a halogen atom.
It is particularly preferred if the inventive agent comprises such reaction products RP according to Formula VIII, in which R7, R8 and R9, according to Formula IX stand, independently of one another for a hydrogen atom, a halogen atom, a C1–C6 alkyl group, a hydroxyl group, a C1–C6 alkoxy group, an amino group, a C1–C6 dialkylamino group, a di(C2–C6 hydroxyalkyl)amino group, a di(C1–C6 alkoxy-C1–C6-alkyl)amino group, a C1–C6 hydroxyalkyloxy group, a sulfonyl group, a carboxyl group, a sulfonamide group, a carbamoyl group, a C2–C6 acyl group, an acetyl group, a sulfonic acid group, a sulfonamide group or a nitro group, with the proviso that if AR stands for benzene, at least one of the radicals R7, R8 or R9 stands for a group selected from a hydroxyl group, a C1–C6 dialkylamino group, a di(C2–C6 hydroxyalkyl)amino group, a di(C1–C6 alkoxy-C1–C6-alkyl)amino group and a C1–C6 hydroxyalkyloxy group.
According to this embodiment, a quite particularly preferred reaction product RP according to Formula VIII comprised in the inventive agents is at least one compound selected from the group consisting of 4-[2-[2-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[4-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,5-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[2,6-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,4-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,5-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,6-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3,4-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3,5-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[2,3,6-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,4,5-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[3,4,6-trihydroxyphenyl]-ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-(2-[2,4,5-trihydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4,6-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[2,3-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,5-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,6-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,4-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,5-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,6-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3,4-trimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3,5-trimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3,6-trimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,4,5-trimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,4,6-trimethoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[2,4,6-trimethoxyphenyl)ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2-hydroxy-3-methoxyphenyl]-ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2-hydroxy-4-methoxyphenyl)ethenyl)-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2-hydroxy-5-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2-hydroxy-6-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[3-hydroxy-2-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-hydroxy-4-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[3-hydroxy-5-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-3-hydroxy-6-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[4-hydroxy-2-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-hydroxy-3-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3-dihydroxy-4-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3-dihydroxy-5-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3-dihydroxy-6-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4-dihydroxy-3-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4-dihydroxy-5-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4-dihydroxy-6-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[2,5-dihydroxy-3-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[2,5-dihydroxy-4-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,5-dihydroxy-6-methoxyphenyl]ethenyl)-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,6-dihydroxy-3-methoxyphenyl]ethenyl)-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,6-dihydroxy-4-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,6-dihydroxy-5-methoxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3-dimethoxy-4-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3-dimethoxy-5-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,3-dimethoxy-6-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4-dimethoxy-3-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4-dimethoxy-5-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,4-dimethoxy-6-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,5-dimethoxy-3-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,5-dimethoxy-4-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[2,5-dimethoxy-6-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,6-dimethoxy-3-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[2,6-dimethoxy-4-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2,6-dimethoxy-5-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,4-dimethoxy-3-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[3,4-dimethoxy-5-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,4-dimethoxy-6-hydroxy-phenyl]-ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[3,5-dimethoxy-2-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,5-dimethoxy-4-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,5-dimethoxy-6-hydroxy-phenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,5-dimethyl-4-hydroxy-phenyl]ethenyl)-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3,5-dimethyl-2-hydroxy-phenyl]-ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-(dimethylamino)-2-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-(dimethylamino)-3-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-(diethylamino)-2-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-(diethylamino)-3-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-(diethylamino)-2-methylphenyl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-(diethylamino)-3-methylphenyl]-ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2-hydroxy-naphth-1-yl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[3-hydroxy-naphth-1-yl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[4-hydroxynaphth-1-yl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4-[2-[2-methoxy]-2,3-dihydro-1,3,6-trimethyl-2-oxopyrimidinium chloride, 4-[2-[3-methoxynaphth-1-yl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxopyrimidinium chloride, 4-[2-[4-methoxynaphth-1-yl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxopyrimidinium chloride, 4-[2-[4-(dimethylamino)naphth-1-yl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4-[2-[4-(diethylamino)-naphth-1-yl]ethenyl]-2,3-dihydro-1,3,6-trimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[3-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[4-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2,3-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4,6-bis[2-[2,4-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2,5-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2,6-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4,6-bis[2-[3,4-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[3,5-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 4,6-bis[2-[3,6-dihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2,3,4-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2,3,5-trihydroxyphenyl)ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2,3,6-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[3,4,5-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2,4,6-trihydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2-methoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[3-methoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[4-methoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2-hydroxy-3-methoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxopyrimidinium chloride, 4,6-bis[2-[2-hydroxy-4-methoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2-hydroxy-5-methoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2-hydroxy-6-methoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2-hydroxy-3,4-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2-hydroxy-3,5-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[2-hydroxy-3,6-methoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[3-hydroxy-2,4-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[3-hydroxy-2,5-dimethoxyphenyl)ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[3-hydroxy-2,6-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[4-hydroxy-2,3-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[4-hydroxy-2,5-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[4-hydroxy-2,6-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[4-hydroxy-3,5-dimethoxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride, 4,6-bis[2-[4-(diethylamino)phenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride and 4,6-bis[2-[4-(diethylamino)-2-hydroxyphenyl]ethenyl]-2,3-dihydro-1,3-dimethyl-2-oxo-pyrimidinium chloride.
The above cited compounds of Formula 1, the compounds of component B, the compounds of component C and the reaction products RP are each preferably used in an amount from 0.03 to 65 mmol, particularly from 1 to 40 mmol based on 100 g of the total colorant.
In a fourth embodiment, the inventive agents comprise, besides at least one compound according to Formula I and at least one reactive carbonyl compound, at least one developer component and optionally one coupler component as oxidation dyestuff precursor.
According to the invention, it can be preferred to use a p-phenylenediamine derivative or one of its physiologically compatible salts as the developer component p-Phenylenediamine derivatives of formula (E1) are particularly preferred
wherein
Examples of substituents of the cited C1 to C4 alkyl radicals in the inventive compounds are the methyl, ethyl, propyl, isopropyl and butyl groups. Ethyl and methyl are preferred alkyl radicals. According to the invention, preferred C1 to C4 alkoxy radicals are, for example, methoxy or ethoxy groups. In addition, preferred examples of a C1 to C4 hydroxyalkyl group can be cited as a hydroxymethyl, a 2-hydroxyethyl, a 3-hydroxypropyl or a 4-hydroxybutyl group. A 2-hydroxyethyl group is particularly preferred. A particularly preferred C2 to C4 polyhydroxyalkyl group is the 1,2-dihydroxyethyl group. According to the invention, examples of halogen atoms are F, Cl or Br atoms, Cl atoms are quite particularly preferred. According to the invention, the terms used later are derived from the definitions given here. Examples of nitrogen-containing groups of formula (E1) are particularly the amino groups, C1 to C4 monoalkylamino groups, C1 to C4 dialkylamino groups, C1 to C4 trialkylamino groups, C1 to C4 monohydroxyalkylamino groups, imadazolinium and ammonium.
Particularly preferred p-phenylenediamines of formula (E1) are selected from p-phenylenediamine, p-toluylenediamine, 2-chloro-p-phenylenediamine, 2,3-dimethyl-p-phenylenediamine, 2,6-dimethyl-p-phenylenediamine, 2,6-diethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, N,N-dimethyl-p-phenylenediamine, N,N-diethyl-p-phenylenediamine, N,N-dipropyl-p-phenylenediamine, 4-amino-3-methyl-(N,N-diethyl)-aniline, N,N-bis-(β-hydroxyethyl)-p-phenylenediamine, 4-N,N-bis-(β-hydroxyethyl)-amino-2-methylaniline, 4-N,N-bis-(β-hydroxyethyl)amino-2-chloroaniline, 2-(β-hydroxyethyl)-p-phenylenediamine, 2-fluoro-p-phenylenediamine, 2-isopropyl-p-phenylenediamine, N-(β-hydroxypropyl)-p-phenylenediamine, 2-hydroxymethyl-p-phenylenediamine, N,N-dimethyl-3-methyl-p-phenylenediamine, N,N-(ethyl-β-hydroxyethyl)-p-phenylenediamine, N-(β,γ-dihydroxypropyl)-p-phenylenediamine, N-(4′-aminophenyl)-p-phenylenediamine, N-phenyl-p-phenylenediamine, 2-(β-hydroxyethyloxy)-p-phenylenediamine, 2-(β-acetylaminoethyloxy)-p-phenylenediamine, N-(β-methoxyethyl)-p-phenylenediamine and 5,8-diaminobenzo-1,4-dioxane and their physiologically compatible salts.
According to the invention, quite particularly preferred p-phenylenediamine derivatives corresponding to formula (E1) are p-phenylenediamine, p-toluylenediamine, 2-(β-hydroxyethyl)-p-phenylenediamine and N,N-bis(β-hydroxyethyl)-p-phenylenediamine.
According to the invention, it can be further preferred to use developer components that are compounds comprising at least two aromatic nuclei substituted by amino and/or hydroxyl groups.
The binuclear developer components, which may be used in the coloring compositions according to the invention, include in particular compounds corresponding to formula (E2) as well as their physiologically compatible salts:
in which:
According to the invention, the substituents used in formula (E2) are as defined in the foregoing embodiments.
Preferred binuclear primary intermediates corresponding to formula (E2) are, in particular, N,N′-bis-(β-hydroxyethyl)-N,N′-bis-(4′-aminophenyl)-1,3-diaminopropan-2-ol, N,N′-bis-(β-hydroxyethyl)-N,N′-bis-(4′-aminophenyl)-ethylenediamine, N,N′-bis-(4-aminophenyl)tetramethylenediamine, N,N′-bis-(β-hydroxyethyl)-N,N′-bis-(4′-aminophenyl)tetramethylenediamine, N,N′-bis-(4-methyl-aminophenyl)tetramethylenediamine, N,N′-bis-(ethyl)-N,N′-bis-(4′-amino-3′-methylphenyl)ethylenediamine, bis-(2-hydroxy-5-aminophenyl)methane, 1,4-bis-(4′-amino-phenyl)diazacycloheptane, N,N′-bis-(2-hydroxy-5-aminobenzyl)-piperazine, N-(4′-aminophenyl)-p-phenylenediamine and 1,10-bis-(2′,5′-diaminophenyl)-1,4,7,10-tetraoxadecane and their physiologically compatible salts.
Quite particularly preferred binuclear developer components of formula (E2) are N,N′-bis-(β-hydroxyethyl)-N,N′-bis-(4′-aminophenyl)-1,3-diaminopropan-2-ol, bis-(2-hydroxy-5-aminophenyl)methane, N,N′-bis-(4′-aminophenyl)-1,4-diazacycloheptane and 1,10-bis-(2′,5′-diaminophenyl)-1,4,7,10-tetraoxadecane or one of their physiologically compatible salts.
According to the invention, it can be further preferred to use a p-aminophenol derivative or one of its physiologically compatible salts as the developer component. p-Aminophenol derivatives of formula (E3) are particularly preferred
in which:
According to the invention, the substituents used in formula (E3) are defined as in the foregoing embodiments.
Preferred p-aminophenols of Formula (E3) are, in particular, p-aminophenol, N-methyl-p-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 2-hydroxymethylamino-4-aminophenol, 4-amino-3-hydroxymethylphenol, 4-amino-2-(2-hydroxyethoxy)phenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethylphenol, 4-amino-2-aminomethylphenol, 4-amino-2-(β-hydroxyethylaminomethyl)phenol, 4-amino-2-(α,β-dihydroxyethyl)phenol, 4-amino-2-fluorophenol, 4-amino-2-chlorophenol, 2,6-dichloro-4-aminophenol, 4-amino-2-(diethylaminomethyl)phenol and their physiologically compatible salts.
Quite particularly preferred compounds corresponding to formula (E3) are p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2-(α,β-dihydroxyethyl)phenol and 4-amino-2-(diethylaminomethyl)phenol.
The developer component may also be selected from o-aminophenol and derivatives thereof such as, for example, 2-amino-4-methylphenol, 2-amino-5-methylphenol or 2-amino-4-chlorophenol.
The developer component may also be selected from heterocyclic developer components such as, for example, the pyridine, pyrimidine, pyrazole, pyrazole-pyrimidine derivatives and physiologically compatible salts thereof.
Preferred pyridine derivatives are particularly the compounds described in the patents GB 1 026 978 and GB 1 153 196, such as 2,5-diaminopyridine, 2-(4′-methoxyphenyl)amino-3-aminopyridine, 2,3-diamino-6-methoxypyridine, 2-(P-methoxyethyl)amino-3-amino-6-methoxypyridine and 3,4-diaminopyridine.
Preferred pyrimidine derivatives are, in particular, the compounds described in German patent DE 2 359 399, Japanese laid-open patent JP 02019576 A2 or the laid-open patent WO 96/15765, such as 2,4,5,6-tetraminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2-dimethylamino-4,5,6-triamino-pyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine and 2,5,6-triaminopyrimidine.
Preferred pyrazole derivatives are, in particular, the compounds described in the patents DE 3 843 892, DE 4 133 957 and patent applications WO 94/08969, WO 94/08970, EP 740 931 and DE 195 43 988, such as 4,5-diamino-1-methylpyrazole, 4,5-diamino-1-(β-hydroxyethyl)pyrazole, 3,4-diaminopyrazole, 4,5-diamino-1-(4′-chlorobenzyl)pyrazole, 4,5-diamino-1,3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenylpyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-tert.butyl-1-methylpyrazole, 4,5-diamino-1-tert.butyl-3-methylpyrazole, 4,5-diamino-1-(β-hydroxyethyl)-3-methylpyrazole, 4,5-diamino-1-ethyl-3-methylpyrazole, 4,5-diamino-1-ethyl-3-(4′-methoxyphenyl)pyrazole, 4,5-diamino-1-ethyl-3-hydroxymethylpyrazole, 4,5-diamino-3-hydroxymethyl-1-methylpyrazole, 4,5-diamino-3-hydroxymethyl-1-isopropylpyrazole, 4,5-diamino-3-methyl-1-isopropylpyrazole, 4-amino-5-(2′-aminoethyl)-amino-1,3-dimethylpyrazole, 3,4,5-triaminopyrazole, 1-methyl-3,4,5-triaminopyrazole, 3,5-diamino-1-methyl-4-methylaminopyrazole and 3,5-diamino-4-(P-hydroxyethyl)-amino-1-methylpyrazole.
Preferred pyrazole-pyrimidine derivatives are, in particular, the derivatives of pyrazole-[1,5-a]-pyrimidine corresponding to formula (E4) below and tautomeric forms thereof, in so far that a tautomeric equilibrium exists:
in which:
According to the invention, the substituents used in formula (E4) are as defined in the foregoing embodiments.
If the pyrazole-[1,5-a]-pyrimidine corresponding to formula (E4) above contains a hydroxyl group in one of the positions 2, 5 or 7 of the ring system, a tautomeric equilibrium exists as illustrated, for example, in the following scheme:
Among the pyrazole-[1,5-a]-pyrimidines corresponding to formula (E4) above, the following may be particularly mentioned:
The pyrazole-[1,5-a]-pyrimidines corresponding to Formula (E4) above may be prepared by cyclization starting from an aminopyrazole or from hydrazine, as described in the literature.
Coupler components optionally comprised in the inventive agents are preferably selected from
According to the invention, particularly preferred coupling components are 1-naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.
In the scope of a fifth embodiment of the present invention, it can be further preferred to add to the inventive agents precursors of a natural dyestuff analog such as indoles and/or indolines which contain at least one hydroxyl or amino group, preferably as a substituent on the six-membered ring. These groups may carry further substituents, for example in the form of an etherified or esterified hydroxyl group or an alkylated amino group. In a second preferred embodiment, the colorants comprise at least one indole and/or indoline derivative.
Derivatives of 5,6-dihydroxyindoline of Formula Xa are particularly good as precursors of natural hair dyestuff analogs,
in which, independently of one another
Particularly preferred derivatives of indoline are 5,6-dihydroxyindoline, N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline, 5,6-dihydroxyindoline-2-carboxylic acid and 6-hydroxyindoline, 6-aminoindoline and 4-aminoindoline.
Within this group, particular emphasis is placed on N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline and, in particular 5,6-dihydroxyindoline. Other particularly suitable precursors of natural hair-dye analogs are derivatives of 5,6-dihydroxyindole corresponding to formula (IIIb):
in which, independently of one another
Particularly preferred derivatives of indole are 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid, 6-hydroxyindole, 6-aminoindole and 4-aminoindole.
Within this group, particular emphasis is placed on N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole and, in particular, 5,6-dihydroxyindole.
The indoline and indole derivatives may be used in the colorants according to the invention both as free bases and in the form of their physiologically compatible salts with inorganic or organic acids, for example, hydrochlorides, sulfates and hydrobromides. The indole or indoline derivatives are normally present in these colorants in amounts of 0.05–10 wt. %, preferably 0.2–5 wt. %.
In a sixth embodiment of the present invention, the inventive hair colorants may comprise, besides the comprised inventive compounds, additional typical substantive dyes for modifying the shades such as nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols. Preferred substantive dyes are the compounds known under the international names or commercial names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, Acid Yellow 1, Acid Yellow 10, Acid Yellow 23, Acid Yellow 36, HC Orange 1, Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, Acid Red 33, Acid Red 52, HC Red BN, Pigment Red. 57:1, HC Blue 2, HC Blue 12, Disperse Blue 3, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse. Black 9, Acid Black 1 and Acid Black 52 as well as 1,4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis-(β-hydroxyethyl)amino-2-nitrobenzene, 3-nitro-4-(β-hydroxyethyl)aminophenol, 2-(2′-hydroxyethyl)amino-4,6-dinitrophenol, 1-(2′-hydroxyethyl)amino-4-methyl-2-nitrobenzene, 1-amino-4-(2′-hydroxyethyl)-amino-5-chloro-2-nitrobenzene, 4-amino-3-nitrophenol, 1-(2′-ureidoethyl)-amino-4-nitrobenzene, 4-amino-2-nitrodiphenylamine-2′-carboxylic acid, 6-nitro-1,2,3,4-tetrahydroquinoxaline, 2-hydroxy-1,4-naphthoquinone, picramic acid and salts thereof, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino-3-nitrobenzoic acid and 2-chloro-6-ethylamino-1-hydroxy-4-nitrobenzene.
Moreover, according to the invention, the inventive compositions may comprise a cationic substantive dye. Particularly preferred thereby are
Preferred cationic substantive dyes of group (c) are, in particular, the following compounds:
The compounds corresponding to formulae (DZ1), (DZ3) and (DZ5), are quite particularly preferred cationic substantive dyestuffs of group (c). The cationic substantive dyestuffs commercialized under the name Arianor® are particularly preferred substantive dyestuffs according to the invention.
The inventive compositions according to this embodiment preferably comprise the substantive dyes in a quantity of 0.01 to 20 wt. %, based on the total colorant.
The preparations according to the invention may also contain naturally occurring dyestuffs such as, for example, henna red, henna neutral, henna black, camomile blossom, sandalwood, black tea, black alder bark, sage, logwood, madder root, catechu, cedar and alkanet root.
It is not necessary for the optionally comprised substantive dyes to each represent homogeneous compounds. Rather, it is possible that because of the synthetic procedures for the individual dyestuffs, further components are present in minor amounts in the inventive colorants, provided that these do not adversely affect the coloration result, or have to be excluded for other reasons, e.g. toxicological grounds.
To obtain further and more intensive colorations the inventive agents can comprise additional color boosters. The color boosters are advantageously selected from the group consisting of piperidine, piperidine-2-carboxylic acid, piperidine-3-carboxylic acid, piperidine-4-carboxylic acid, pyridine, 2-hydroxypyridine, 3-hydroxypyridine, 4-hydroxypyridine, imidazole, 1-methylimidazole, arginine, histidine, pyrrolidine, proline, pyrrolidone, pyrrolidone-5-carboxylic acid, pyrazole, 1,2,4-triazole, piperazidine, their derivatives and their physiologically compatible salts.
The above named color boosters can each be used in a quantity of 0.03 to 65 mmol, particularly 1 to 40 mmol, each based on 100 g of the total colorant.
The presence of oxidizing agents, e.g. H2O2 can be avoided, particularly if the inventive agent does not contain any oxidation dyestuff precursors. If the inventive agent contains air-oxidizable oxidation dyestuff precursors or indole or indoline derivatives, then in such a case the oxidizing agents can be avoided without problem. Under certain circumstances, however, it may be desirable to add hydrogen peroxide or other oxidizing agents to the inventive agents in order to achieve shades that are lighter than the keratin-containing fibers that are being dyed. Oxidizing agents are generally added in an amount from 0.01 to 6 wt. % based on the application solution. A preferred oxidizing agent for human hair is H2O2. Mixtures of a plurality of oxidizing agents, such as, for example a combination of hydrogen peroxide and peroxydisulfates of the alkali- and earth alkali metals or from iodide ion sources, such as, for example alkali metal iodides and hydrogen peroxide or the above-cited peroxydisulfates can also be used. According to the invention, the oxidizing agent and the oxidizing agent combination can be used in combination with oxidation catalysts in the hair colorant. Exemplary oxidation catalysts are metal salts, metal chelate complexes or metal oxides, which enable a facile transition between two oxidation states of the metal ions. Examples are salts, chelate complexes or oxides of iron, ruthenium, manganese and copper. Other possible oxidation catalysts are enzymes. Suitable enzymes are e.g. peroxidases, which can markedly enhance the effect of minor amounts of hydrogen peroxide. According to the invention, such enzymes are moreover suited to directly oxidize the oxidation dyestuff precursors with oxygen in the air, such as, for example the laccases, or to produce minor quantities of hydrogen peroxide in situ and in this manner biocatalytically activate the oxidation of the dyestuff precursors. Particularly suitable catalysts for the oxidation of the dyestuff precursors are the so-called 2-electron oxido-reductases combined with the specific substrates for them, e.g.
The inventive colorants produce intensive colorations already at physiologically acceptable temperatures below 45° C. They are thus particularly suitable for dyeing human hair. For use on human hair, the colorants are usually mixed into an aqueous cosmetic carrier. Suitable aqueous cosmetic carriers are, for example, creams, emulsions, gels or other foaming solutions that contain surfactants, such as, for example shampoos or other preparations suitable for application on keratin-containing fibers. When required, it is also possible to mix the colorant into an anhydrous carrier.
The colorants according to the invention may also contain any of the known active substances, additives and auxiliaries typical of such preparations. In many cases, the colorants contain at least one surfactant, both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants being suitable in principle. In many cases, however, it has been found to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
Suitable anionic surfactants for the preparations according to the invention are any anionic surface-active substances suitable for use on the human body. Such substances are characterized by a water-solubilizing anionic group such as, for example, a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group containing around 10 to 22 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether, amide and hydroxyl groups may also be present in the molecule. The following are examples of suitable anionic surfactants, each in the form of the sodium, potassium and ammonium salts as well as mono-, di- and trialkanolammonium salts containing 2 or 3 carbon atoms in the alkanol group,
Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids containing 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule as well as particularly salts of saturated and particularly unsaturated C8–C22 carboxylic acids such as oleic acid stearic acid, isostearic acid and palmitic acid.
Zwitterionic surfactants are defined as surface-active compounds, which contain at least one quaternary ammonium group and at least one —COO(−) or —SO3(−) group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines, such as N-alkyl-N,N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N,N-dimethyl ammonium glycinates, for example cocoacylaminopropyl dimethyl ammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl imidazolines containing 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethyl hydroxyethyl carboxymethyl glycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known by the CTFA name of Cocamidopropyl Betaine.
Ampholytic surfactants are understood to be such surface-active compounds which, in addition to a C8–C18 alkyl or acyl group, contain at least one free amino group and at least one —COOH or —SO3H group in the molecule and which are capable of forming internal salts. Examples of suitable ampholytic surfactants are N-alkyl glycines, N-alkyl propionic acids, N-alkyl aminobutyric acids, N-alkyl iminodipropionic acids, N-hydroxyethyl-N-alkyl amidopropyl glycines, N-alkyl taurines, N-alkyl sarcosines, 2-alkyl aminopropionic acids and alkyl aminoacetic acids each containing around 8 to 18 carbon atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkyl aminopropionate, cocoacyl aminoethyl aminopropionate and C12–C18 acylsarcosine.
Nonionic surfactants contain as the hydrophilic group for example a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether groups. Examples of such compounds are
Examples of cationic surfactants suitable for the inventive hair treatment agents are particularly quaternary ammonium compounds. Ammonium halides, such as alkyl trimethyl ammonium chlorides, dialkyl dimethyl ammonium chlorides and trialkyl methyl ammonium chlorides, for example cetyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, lauryl dimethyl ammonium chloride, lauryl dimethyl benzyl ammonium chloride and tricetyl methyl ammonium chloride. Other suitable cationic surfactants according to the invention are represented by quaternized protein hydrolyzates.
According to the invention, also suitable are cationic silicone oils such as, for example the commercially available products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethylsilylamodimethicone), Dow Corning® 929 Emulsion (comprising a hydroxylamino-modified silicone, which is also referred to as amodimethicone), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil®-Quat 3270 and 3272 (manufacturer: Th. Goldschmidt; diquaternary polydimethylsiloxanes, Quaternium-80).
Alkylamidoamines, particularly fatty acid amidoamines such as stearylamido propyl dimethyl amine, available under the name Tego Amid®S 18, are characterized by a good conditioning action, especially by their good biodegradability.
Quaternary ester compounds, known as “esterquats” likewise have good biodegradability such as methylhydroxyalkyldialkoyloxyalkylammonium methosulfate commercialized under the trade name Stepantex®.
An example of a suitable cationic surfactant quaternary sugar derivative is the commercial product Glucquat®100, a “lauryl methyl gluceth-10 hydroxypropyl dimonium chloride” according to CTFA nomenclature.
The compounds used as surfactants with alkyl groups may each be homogeneous compounds. In general, however, these compounds are preferably produced from natural vegetal or animal raw materials and result in mixtures of products with raw material-dependent, different alkyl chain lengths.
The surfactants representing addition products of ethylene and/or propylene oxide with fatty alcohols or derivatives of these addition products may be both products with a “normal” homolog distribution and products with a narrow homolog distribution. Products with a “normal” homolog distribution are mixtures of homologs which are obtained from the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates as catalysts. By contrast, narrow homolog distributions are obtained when, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alcoholates are used as catalysts. The use of products with a narrow homolog distribution can be preferred.
Further active products, adjuvants and additives are for example
For the manufacture of the inventive colorant, the constituents of the aqueous carrier are added in typical quantities for this application; e.g. emulsifiers are added in concentrations from 0.5 to 30 wt. % and thickeners in concentrations from 0.1 to 25 wt. % of the total colorant.
For the color result it can be advantageous to add ammonium or metal salts to the colorant. Suitable metal salts are e.g. formates, carbonates, halides, sulfates, butyrates, valeriates, capronates, acetates, lactates, glycolates, tartrates, citrates, gluconates, propionates, phosphates and phosphonates of alkali metals, such as potassium, sodium or lithium, earth alkali metals such as magnesium, calcium, strontium or barium, or aluminum, manganese, iron, cobalt, copper or zinc, wherein sodium acetate, lithium bromide, calcium bromide, calcium gluconate, zinc chloride, zinc sulfate, magnesium chloride, magnesium sulfate, ammonium carbonate, -chloride and -acetate are preferred. These salts are preferably comprised in a quantity of 0.03 to 65 mmol, particularly 1 to 40 mmol based on 100 g of the total colorant.
The pH of the ready-to-use dye preparations lies typically between 2 and 11, preferably between 5 and 10.
A second subject of the invention is colorants for keratin-containing fibers, particularly human hair, comprising the reaction products RP according to Formula VIII as coloring components,
in which
in which
It is particularly preferred if the inventive agent comprises such reaction products RP according to Formula VIII in which AR according to Formula IX stands for benzene or naphthalene.
Further, it is particularly preferred if the inventive agent comprises such reaction products according to Formula VIII in which Z according to Formula IX stands for a direct bond or vinylene.
It is particularly preferred if the inventive agent comprises such reaction products RP according to Formula VIII in which R25 according to Formula IX stands for a hydrogen atom.
It is particularly preferred if the inventive agent comprises such reaction products RP according to Formula VIII in which R6 according to Formula IX stands for a hydrogen atom.
It is particularly preferred if the inventive agents comprise such reaction products RP according to Formula VIII in which R7, R8 and R9 according to Formula IX, independently of one another stand for a hydrogen atom, a halogen atom, a C1–C6 alkyl group, a hydroxyl group, a C1–C6 alkoxy group, an amino group, a C1–C6 dialkylamino group, a di(C2–C6 hydroxyalkyl)amino group, a di(C1–C6 alkoxy-C1–C6-alkyl)amino group, a C1–C6 hydroxyalkyloxy group, a sulfonyl group, a carboxyl group, a sulfonamide group, a carbamoyl group, a C2–C6 acyl group, an acetyl group, a sulfonic acid group, a sulfonamide group or a nitro group.
It is particularly preferred if the inventive agents comprise such reaction products RP according to Formula VIII in which R7, R8 and R9 according to Formula IX, independently of one another stand for a hydrogen atom, a halogen atom, a C1–C6 alkyl group, a hydroxyl group, a C1–C6 alkoxy group, an amino group, a C1–C6 dialkylamino group, a di(C2–C6 hydroxyalkyl)amino group, a di(C1–C6 alkoxy-C1–C6-alkyl)amino group, a C1–C6 hydroxyalkyloxy group, a sulfonyl group, a carboxyl group, a sulfonamide group, a carbamoyl group, a C2–C6 acyl group, an acetyl group, a sulfonic acid group, a sulfonamide group or a nitro group, with the proviso that if AR stands for benzene and one of the radicals R7, R8 or R9 para to group Z stands for a hydrogen atom, a halogen atom, a C1–C6 alkoxy group or an amino group then both the other radicals, independently of one another mean neither a hydrogen atom nor a halogen atom.
It is particularly preferred if the inventive agents comprise such reaction products RP according to Formula VIII in which R7, R8 and R9 according to Formula IX, independently of one another stand for a hydrogen atom, a halogen atom, a C1–C6 alkyl group, a hydroxyl group, a C1–C6 alkoxy group, an amino group, a C1–C6 dialkylamino group, a di(C2–C6 hydroxyalkyl)amino group, a di(C1–C6 alkoxy-C1–C6-alkyl)amino group, a C1–C6 hydroxyalkyloxy group, a sulfonyl group, a carboxyl group, a sulfonamide group, a carbamoyl group, a C2–C6 acyl group, an acetyl group, a sulfonic acid group, a sulfonamide group or a nitro group, with the proviso that at least one of the radicals R7, R8 or R9 para to group Z stands for a group that is selected from a hydroxyl group, a C1–C6 dialkylamino group, a di(C2–C6 hydroxyalkyl)amino group, a di(C1–C6 alkoxy-C1–C6-alkyl)amino group and a C1–C6 hydroxyalkyloxy group.
The particularly preferred compounds according to Formula VIII are the compounds cited in the first subject matter of the invention.
The reaction product RP is preferably comprised in the agents in an amount from 0.03 to 65 mmol, particularly from 1 to 40 mmol, based on 100 g of the total colorant.
These colorants can additionally comprise
Moreover, all surfactants, color boosters, metal salts or oxidizing agents as well as additional adjuvants, active substances and additives that were already mentioned above, can be comprised in the inventive agent of the second subject matter of the invention.
A third subject-matter of the present invention relates to the use of at least one 1,2-dihydropyrimidinium derivative according to Formula 1 and/or its enamine form,
wherein R1, R2, R3, R4, R5, Y and X− are as defined above, in combination with at least one reactive carbonyl compound (component B) as the coloring component in hair colorants.
In a preferred embodiment, the 1,2-dihydropyrimidinium derivatives according to Formula I are used in combination with at least one reactive carbonyl compound of the component B selected from the previous cited preferred and particularly preferred representatives, as the coloring component in hair colorants.
Moreover, it can be preferred to use at least one reaction product RP of a 1,2-dihydropyridinium derivative according to Formula I and a compound of component B as the coloring components in hair colorants.
A fourth subject-matter of the present invention relates to a process for dyeing keratin-containing fibers, particularly human hair, wherein a colorant comprising at least one 1,2-dihydropyrimidinium derivative according to Formula 1 and/or its enamine form,
wherein R1, R2, R3, R4, R5, Y and X− are as defined above, in combination with at least one compound with a reactive carbonyl group (component B), as well as customary cosmetic ingredients are applied to the keratin-containing fibers for some time, normally 15–30 minutes, left on the fibers and subsequently rinsed out or washed out with a shampoo. During the contact time of the agent on the fibers, it can be advantageous to support the dyeing procedure by providing heat. The heat can be supplied from an external heat source, such as e.g. warm air from a hairdryer or also, particularly with a hair coloration on living test persons, by means of the body temperature of the test persons. The latter option is usually by means of a hood covering over the parts to be dyed.
In doing so, the 1,2-dihydrpyrimidinium derivatives according to Formula I and the compounds of component B, particularly their representatives cited above as being preferred and particularly preferred, are applied to the hair as color-providing components either simultaneously or one after the other, i.e. in a multi-step process in which it is unimportant which of the components is applied first. The optionally contained ammonium or metal salts can be added here to the compounds of Formula I or to the compounds of component B. There can be an interval of up to 30 minutes between the application of the individual components. It is also possible to pretreat the fibers with the salt solution.
If desired, the keratin-containing fibers that are to be dyed can be pretreated before the application of the inventive agent in the inventive process. The chronology of the required pretreatment step and the application of the inventive agent must not be immediately one after the other, as there can be an interval of up to a maximum of two weeks between the pretreatment step and the application of the inventive agent. A plurality of pretreatment methods is suitable for this purpose. Preferably, the fiber is subjected to
In the context of the pretreatment V1, the keratin-containing fiber is treated with a bleach. In addition to an oxidizing agent, typically hydrogen peroxide, the bleach preferably contains at least one inorganic peroxy salt as active oxidizing booster and bleach booster, such as, e.g. a peroxydisulfate of sodium, potassium or ammonium. The pretreatment V1 provides a particular brilliance and color depth to the coloration according to the inventive process.
In the context of the pretreatment V2, the fiber is treated with a composition comprising the afore mentioned oxidation dyestuff precursors as developer and optional coupler components, together with optional afore mentioned derivatives of indole or indoline, and with an optional addition of suitable afore mentioned oxidizing agents to the hair, and left on the keratin fibers for a contact time of 5 to 45 minutes. The hair is then washed. By a final application of the inventive agent, a new shade of color can be imparted to the existent oxidation colorations. By choosing a color shade of the inventive agent in the same shade as the oxidative coloration, this enables, after the inventive process, the coloration of the existent oxidation coloration to be restored. It turns out that the color restoration or shading according to the inventive process is superior in color brilliance and color depth to a color restoration or shading made solely with customary substantive dyestuffs.
If in addition to the compounds according to Formula I and the optional component B, the hair colorant contains hydrogen peroxide or an oxidizing agent mixture that contains hydrogen peroxide, then the pH of the hydrogen peroxide-containing hair colorant preferably lies in a pH range of pH 7 to pH 11, particularly preferably pH 8 to pH 10. The oxidizing agent can be mixed with the hair colorant immediately prior to use and the mixture applied to the hair. When the compounds of Formula I and the component B are applied to the hair in a two-step process, the oxidizing agent is used together with the corresponding coloring components in one of the two process steps. For this purpose, it can be preferred to mix the oxidizing agent with one of the coloring components in a container.
The 1,2-dihydropyrimidinium derivatives according to Formula I and the compounds of component B can either be stored separately or together, either in a liquid to pasty preparation (aqueous or anhydrous) or as dry powder. If the components are stored together in a liquid preparation, then this should be substantially anhydrous in order to reduce any reaction of the components. For separate storage, the reactive components are to be well mixed together immediately prior to their use. For dry storage, normally a defined amount of warm water (30° C. to 80° C.) is added prior to usage and a homogeneous mixture is prepared.
A fifth subject of the invention is the use of at least one 1,2-dihydropyrimidinium derivative according to Formula 1, and/or its enamine form,
wherein R1, R2, R3, R4, R5, Y and X− are as defined above, in combination with at least one reactive carbonyl compound (component B) for shading the oxidation colorations of keratin-containing fibers, particularly human hair. On usage it is immaterial if the shading occurs simultaneously to the oxidative coloration or if the oxidative coloration occurrs prior to the shading.
A sixth subject of the invention is the use of at least one 1,2-dihydropyrimidinium derivative according to Formula I1, and/or its enamine form,
wherein, R1, R2; R3, R4, R5, Y and X− are as defined above, in combination with at least one reactive carbonyl compound (component B) for restoring the color of keratin-containing fibers dyed with oxidative colorants.
The colorations of keratin-containing fibers are known to be affected by environmental influences, such as, for example, light, rubbing or washing and can thereby lose in brilliance and color depth. In the worst case, a shift in color of the shade may occur. When the user wishes, such aged colorations of keratin-containing fibers can be restored by a color refreshment to present a color close to that of the original coloration. According to the invention, a combination of at least one compound of Formula I and at least one reactive carbonyl compound is used for such a color restoration.
Preparation of a Colorant Solution.
Each slurry or solution was prepared at about 50° C. with 3 mmol of 1,2-dihydropyrimidinium derivative of Formula I (component A) with 0.41 g sodium acetate in 30 ml water. 3 mmol of the compound of component B are added to this mixture immediately prior to use. The mixture was adjusted either to pH 9 with a 10% aqueous sodium hydroxide solution or to pH 4 or 6 with hydrochloric acid (see Table 1).
Coloring Tests
A strand of 90% gray, un-pretreated human hair was placed in the freshly prepared colorant solution for 30 minutes at 30° C. The strand was then rinsed with luke-warm water for 30 seconds, dried with warm air (30° C. to 40° C.) and finally combed out.
Each color shade and color depth of the color-test examples are presented in the following Table 1.
Compounds of Component A (in Table 1);
Compounds of Component B (in Table 1):
| Number | Date | Country | Kind |
|---|---|---|---|
| 102 41 076 | Sep 2002 | DE | national |
This application is a continuation under 35 U.S.C. § 365 and 35 U.S.C. § 120 of international application PCT/EP2003/009366, filed on Aug. 23, 2003. This application also claims priority under 35 U.S.C. § 119 of DE 102 41 076.3, filed Sep. 5, 2002, which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3574200 | Brack | Apr 1971 | A |
| 4865774 | Fabry et al. | Sep 1989 | A |
| 4931218 | Schenker et al. | Jun 1990 | A |
| 5061289 | Clausen et al. | Oct 1991 | A |
| 5279616 | Lang et al. | Jan 1994 | A |
| 5294726 | Behler et al. | Mar 1994 | A |
| 5380340 | Neunhoeffer et al. | Jan 1995 | A |
| 5534267 | Neunhoeffer et al. | Jul 1996 | A |
| 5663366 | Neunhoeffer et al. | Sep 1997 | A |
| 5725607 | Giera et al. | Mar 1998 | A |
| 5766576 | Lowe et al. | Jun 1998 | A |
| 6099592 | Vidal et al. | Aug 2000 | A |
| 6284003 | Rose et al. | Sep 2001 | B1 |
| 6635090 | Andrean et al. | Oct 2003 | B1 |
| Number | Date | Country |
|---|---|---|
| 2 288 253 | May 2000 | CA |
| 2 047 431 | Mar 1972 | DE |
| 2047431 | Mar 1972 | DE |
| 2 165 913 | Jul 1973 | DE |
| 23 59 399 | Jun 1975 | DE |
| 37 23 354 | Jan 1989 | DE |
| 37 25 030 | Feb 1989 | DE |
| 38 43 892 | Jun 1990 | DE |
| 39 26 344 | Feb 1991 | DE |
| 41 33 957 | Apr 1993 | DE |
| 195 43 988 | May 1997 | DE |
| 299 08 573 | Sep 1999 | DE |
| 101 48 847 | Apr 2003 | DE |
| 0 740 931 | Aug 1997 | EP |
| 0 873 745 | Oct 1998 | EP |
| 0 998 908 | May 2000 | EP |
| 2 787 707 | Jun 2000 | FR |
| 1 026 978 | Apr 1966 | GB |
| 1 153 196 | May 1969 | GB |
| 1 386 269 | Mar 1975 | GB |
| 1 486 576 | Sep 1977 | GB |
| 02-019576 | Jan 1990 | JP |
| 2002-47153 | Feb 2002 | JP |
| WO 9408969 | Apr 1994 | WO |
| WO 9408970 | Apr 1994 | WO |
| WO 9515144 | Jun 1995 | WO |
| WO 9615765 | May 1996 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20050144740 A1 | Jul 2005 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/EP03/09366 | Aug 2003 | US |
| Child | 11069745 | US |
